UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended December 31, 2024
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission File Number 001-38932
AMCOR PLC
(Exact name of Registrant as specified in its charter) | | | | | | | | |
Jersey | | 98-1455367 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
83 Tower Road North
Warmley, Bristol BS30 8XP
United Kingdom
(Address of principal executive offices)
Registrant’s telephone number, including area code: +44 117 9753200
Securities registered pursuant to Section 12(b) of the Act: | | | | | | | | | | | | | | |
Title of each class | | Trading symbol(s) | | Name of each exchange on which registered |
Ordinary Shares, Par Value $0.01 Per Share | | AMCR | | New York Stock Exchange |
1.125% Guaranteed Senior Notes Due 2027 | | AUKF/27 | | New York Stock Exchange |
5.450% Guaranteed Senior Notes Due 2029 | | AMCR/29 | | New York Stock Exchange |
3.950% Guaranteed Senior Notes Due 2032 | | AMCR/32 | | New York Stock Exchange |
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one): | | | | | | | | | | | |
Large Accelerated Filer | ☒ | Emerging Growth Company | ☐ |
Non-Accelerated Filer | ☐ | Smaller Reporting Company | ☐ |
Accelerated Filer | ☐ | | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of February 3, 2025, the registrant had 1,445,343,212 ordinary shares, $0.01 par value, outstanding.
Amcor plc
Quarterly Report on Form 10-Q
Cautionary Statement Regarding Forward-Looking Statements
Unless otherwise indicated, references to "Amcor," the "Company," "we," "our," and "us" in this Quarterly Report on Form 10-Q refer to Amcor plc and its consolidated subsidiaries.
This Quarterly Report on Form 10-Q contains certain statements that are "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identified with words like "believe," "expect," "target," "project," "may," "could," "would," "approximately," "possible," "will," "should," "intend," "plan," "anticipate," "commit," "estimate," "potential," "ambitions," "outlook," or "continue," the negative of these words, other terms of similar meaning, or the use of future dates. Such statements are based on the current expectations of the management of Amcor and are qualified by the inherent risks and uncertainties surrounding future expectations generally. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. Neither Amcor nor any of its respective directors, executive officers, or advisors, provide any representation, assurance, or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur or if any of them do occur, what impact they will have on the business, results of operations or financial condition of Amcor. Should any risks and uncertainties develop into actual events, these developments could have a material adverse effect on Amcor's business, the proposed Transaction and the ability to successfully complete the proposed Transaction and realize its expected benefits. Risks and uncertainties that could cause actual results to differ from expectations include, but are not limited to:
•occurrence of any event, change or other circumstance that could give rise to the termination of the Agreement and Plan of Merger ("Merger Agreement") in connection with the proposed merger (the "Transaction") of Amcor and Berry Global Group, Inc. ("Berry");
•risk that the conditions to the completion of the proposed Transaction with Berry (including shareholder and regulatory approvals) are not satisfied in a timely manner or at all;
•risks arising from the integration of the Amcor and Berry businesses;
•risk that the anticipated benefits of the proposed Transaction may not be realized when expected or at all;
•risk of unexpected costs or expenses resulting from the proposed Transaction;
•risk of litigation related to the proposed Transaction;
•risks related to the disruption of management's time from ongoing business operations as a result of the proposed Transaction;
•risk that the proposed Transaction may have an adverse effect on our ability to retain key personnel and customers;
•general economic, market and social developments and conditions;
•evolving legal, regulatory and tax regimes under which we operate;
•potential business uncertainty, including changes to existing business relationships, during the pendency of the proposed Transaction that could affect our financial performance;
•changes in consumer demand patterns and customer requirements in numerous industries;
•the loss of key customers, a reduction in their production requirements, or consolidation among key customers;
•significant competition in the industries and regions in which we operate;
•an inability to expand our current business effectively through either organic growth, including product innovation, investments, or acquisitions;
•challenging global economic conditions;
•impacts of operating internationally;
•price fluctuations or shortages in the availability of raw materials, energy and other inputs, which could adversely affect our business;
•production, supply, and other commercial risks, including counterparty credit risks, which may be exacerbated in times of economic volatility;
•pandemics, epidemics, or other disease outbreaks;
•an inability to attract and retain our global executive team and our skilled workforce and manage key transitions;
•labor disputes and an inability to renew collective bargaining agreements at acceptable terms;
•physical impacts of climate change;
•cybersecurity risks, which could disrupt our operations or risk of loss of our sensitive business information;
•failures or disruptions in our information technology systems which could disrupt our operations, compromise customer, employee, supplier, and other data;
•a significant increase in our indebtedness or a downgrade in our credit rating could reduce our operating flexibility and increase our borrowing costs and negatively affect our financial condition and results of operations;
•rising interest rates that increase our borrowing costs on our variable rate indebtedness and could have other negative impacts;
•foreign exchange rate risk;
•a significant write-down of goodwill and/or other intangible assets;
•a failure to maintain an effective system of internal control over financial reporting;
•an inability of our insurance policies, including our use of a captive insurance company, to provide adequate protection against all of the risks we face;
•an inability to defend our intellectual property rights or intellectual property infringement claims against us;
•litigation, including product liability claims or litigation related to Environmental, Social, and Governance ("ESG") matters, or regulatory developments;
•increasing scrutiny and changing expectations from investors, customers, suppliers, and governments with respect to our ESG practices and commitments resulting in additional costs or exposure to additional risks;
•changing ESG government regulations including climate-related rules;
•changing environmental, health, and safety laws; and
•changes in tax laws or changes in our geographic mix of earnings.
These risks and uncertainties are supplemented by those identified from time to time in our filings with the Securities and Exchange Commission (the "SEC"), including without limitation, those described under Part I, "Item 1A - Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024, and as updated by our quarterly reports on Form 10-Q. You can obtain copies of Amcor’s filings with the SEC for free at the SEC’s website (www.sec.gov). Forward-looking statements included herein are made only as of the date hereof and Amcor does not undertake any obligation to update any forward-looking statements, or any other information in this communication, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent, except as expressly required by law. All forward-looking statements in this communication are qualified in their entirety by this cautionary statement.
Part I - Financial Information
Item 1. Financial Statements (unaudited)
Amcor plc and Subsidiaries
Condensed Consolidated Statements of Income
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended December 31, | | Six Months Ended December 31, |
($ in millions, except per share data) | | 2024 | | 2023 | | 2024 | | 2023 |
Net sales | | $ | 3,241 | | | $ | 3,251 | | | $ | 6,594 | | | $ | 6,694 | |
Cost of sales | | (2,615) | | | (2,630) | | | (5,309) | | | (5,428) | |
| | | | | | | | |
Gross profit | | 626 | | | 621 | | | 1,285 | | | 1,266 | |
| | | | | | | | |
| | | | | | | | |
Selling, general, and administrative expenses | | (295) | | | (299) | | | (610) | | | (601) | |
Research and development expenses | | (27) | | | (28) | | | (55) | | | (55) | |
Restructuring and other activities, net | | (33) | | | (24) | | | (39) | | | (52) | |
Other income/(expenses), net | | 26 | | | (28) | | | 28 | | | (46) | |
| | | | | | | | |
Operating income | | 297 | | | 242 | | | 609 | | | 512 | |
| | | | | | | | |
Interest income | | 9 | | | 11 | | | 20 | | | 21 | |
Interest expense | | (81) | | | (89) | | | (167) | | | (174) | |
Other non-operating income/(expenses), net | | (1) | | | 1 | | | (2) | | | — | |
| | | | | | | | |
Income before income taxes and equity in income/(loss) of affiliated companies | | 224 | | | 165 | | | 460 | | | 359 | |
| | | | | | | | |
Income tax expense | | (58) | | | (28) | | | (101) | | | (67) | |
Equity in income/(loss) of affiliated companies, net of tax | | 1 | | | (1) | | | 1 | | | (2) | |
| | | | | | | | |
Net income | | $ | 167 | | | $ | 136 | | | $ | 360 | | | $ | 290 | |
| | | | | | | | |
Net income attributable to non-controlling interests | | (4) | | | (2) | | | (6) | | | (4) | |
| | | | | | | | |
Net income attributable to Amcor plc | | $ | 163 | | | $ | 134 | | | $ | 354 | | | $ | 286 | |
| | | | | | | | |
Basic earnings per share: | | $ | 0.113 | | | $ | 0.093 | | | $ | 0.245 | | | $ | 0.198 | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Diluted earnings per share: | | $ | 0.113 | | | $ | 0.092 | | | $ | 0.244 | | | $ | 0.198 | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Note: Per share amounts may not add due to rounding. See accompanying notes to condensed consolidated financial statements.
Amcor plc and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended December 31, | | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 | | 2024 | | 2023 |
Net income | | $ | 167 | | | $ | 136 | | | $ | 360 | | | $ | 290 | |
Other comprehensive income/(loss): | | | | | | | | |
Net gains on cash flow hedges, net of tax (a) | | 3 | | | 2 | | | 4 | | | 3 | |
Foreign currency translation adjustments, net of tax (b) | | (106) | | | 99 | | | (105) | | | 31 | |
Excluded components of fair value hedges | | (22) | | | — | | | (11) | | | — | |
Pension, net of tax (c) | | (3) | | | — | | | (2) | | | 1 | |
Other comprehensive income/(loss) | | (128) | | | 101 | | | (114) | | | 35 | |
Total comprehensive income | | 39 | | | 237 | | | 246 | | | 325 | |
Comprehensive income attributable to non-controlling interests | | (4) | | | (2) | | | (6) | | | (4) | |
Comprehensive income attributable to Amcor plc | | $ | 35 | | | $ | 235 | | | $ | 240 | | | $ | 321 | |
| | | | | | | | |
(a) Tax expense related to cash flow hedges | | $ | — | | | $ | (1) | | | $ | (1) | | | $ | (1) | |
(b) Tax benefit/(expense) related to foreign currency translation adjustments | | $ | (4) | | | $ | 3 | | | $ | (3) | | | $ | 2 | |
| | | | | | | | |
(c) Tax benefit related to pension adjustments | | $ | 1 | | | $ | — | | | $ | 1 | | | $ | — | |
See accompanying notes to condensed consolidated financial statements.
Amcor plc and Subsidiaries
Condensed Consolidated Balance Sheets
(Unaudited)
| | | | | | | | | | | | | | |
($ in millions, except share and per share data) | | December 31, 2024 | | June 30, 2024 |
Assets | | | | |
Current assets: | | | | |
Cash and cash equivalents | | $ | 445 | | | $ | 588 | |
Trade receivables, net of allowance for credit losses of $22 and $24, respectively | | 1,775 | | | 1,846 | |
Inventories, net: | | | | |
Raw materials and supplies | | 927 | | | 862 | |
Work in process and finished goods | | 1,199 | | | 1,169 | |
Prepaid expenses and other current assets | | 559 | | | 500 | |
| | | | |
Total current assets | | 4,905 | | | 4,965 | |
Non-current assets: | | | | |
| | | | |
Property, plant, and equipment, net | | 3,629 | | | 3,763 | |
Operating lease assets | | 537 | | | 567 | |
Deferred tax assets | | 145 | | | 148 | |
Other intangible assets, net | | 1,317 | | | 1,391 | |
Goodwill | | 5,273 | | | 5,345 | |
Employee benefit assets | | 34 | | | 34 | |
Other non-current assets | | 325 | | | 311 | |
Total non-current assets | | 11,260 | | | 11,559 | |
Total assets | | $ | 16,165 | | | $ | 16,524 | |
Liabilities | | | | |
Current liabilities: | | | | |
Current portion of long-term debt | | $ | 13 | | | $ | 12 | |
Short-term debt | | 91 | | | 84 | |
Trade payables | | 2,380 | | | 2,580 | |
Accrued employee costs | | 292 | | | 399 | |
Other current liabilities | | 1,121 | | | 1,186 | |
| | | | |
Total current liabilities | | 3,897 | | | 4,261 | |
Non-current liabilities: | | | | |
Long-term debt, less current portion | | 6,837 | | | 6,603 | |
Operating lease liabilities | | 458 | | | 488 | |
Deferred tax liabilities | | 553 | | | 584 | |
Employee benefit obligations | | 200 | | | 217 | |
Other non-current liabilities | | 429 | | | 418 | |
Total non-current liabilities | | 8,477 | | | 8,310 | |
Total liabilities | | $ | 12,374 | | | $ | 12,571 | |
| | | | |
Commitments and contingencies (See Note 17) | | | | |
| | | | |
Shareholders' Equity | | | | |
Amcor plc shareholders’ equity: | | | | |
Ordinary shares ($0.01 par value) | | | | |
Authorized (9,000 million shares) | | | | |
Issued (1,445 and 1,445 million shares, respectively) | | $ | 14 | | | $ | 14 | |
Additional paid-in capital | | 4,045 | | | 4,019 | |
Retained earnings | | 869 | | | 879 | |
Accumulated other comprehensive loss | | (1,134) | | | (1,020) | |
Treasury shares (1 and 1 million shares, respectively) | | (10) | | | (11) | |
Total Amcor plc shareholders' equity | | 3,784 | | | 3,881 | |
Non-controlling interests | | 7 | | | 72 | |
Total shareholders' equity | | 3,791 | | | 3,953 | |
Total liabilities and shareholders' equity | | $ | 16,165 | | | $ | 16,524 | |
See accompanying notes to condensed consolidated financial statements.
Amcor plc and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Unaudited) | | | | | | | | | | | | | | |
| | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 |
Cash flows from operating activities: | | | | |
Net income | | $ | 360 | | | $ | 290 | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | | |
Depreciation, amortization, and impairment | | 267 | | | 295 | |
Net periodic benefit cost | | 9 | | | 7 | |
Amortization of debt discount and other deferred financing costs | | 7 | | | 5 | |
| | | | |
Net gain on disposal of property, plant, and equipment | | — | | | (1) | |
Net gain on disposal of businesses | | (8) | | | — | |
Equity in (income)/loss of affiliated companies | | (1) | | | 2 | |
Net foreign exchange loss | | — | | | 35 | |
Share-based compensation | | 18 | | | 6 | |
Other, net | | 20 | | | (47) | |
Loss from highly inflationary accounting for Argentine subsidiaries | | 17 | | | 86 | |
Deferred income taxes, net | | (27) | | | (5) | |
| | | | |
Changes in operating assets and liabilities, excluding effect of acquisitions, divestitures, and currency | | (503) | | | (445) | |
Net cash provided by operating activities | | 159 | | | 228 | |
Cash flows from investing activities: | | | | |
| | | | |
Investments in affiliated companies and other | | — | | | (3) | |
Business acquisitions | | (11) | | | (19) | |
Purchase of property, plant, and equipment, and other intangible assets | | (243) | | | (245) | |
Proceeds from divestitures, net of cash divested | | 113 | | | — | |
Proceeds from sales of property, plant, and equipment, and other intangible assets | | 7 | | | 11 | |
Net cash used in investing activities | | (134) | | | (256) | |
Cash flows from financing activities: | | | | |
Proceeds from exercise of options | | 14 | | | — | |
| | | | |
Purchase of treasury shares and tax withholdings for share-based incentive plans | | (52) | | | (51) | |
| | | | |
| | | | |
Proceeds from issuance of long-term debt | | 2 | | | — | |
Repayment of long-term debt | | (2) | | | (21) | |
Financing-related transaction fees | | (11) | | | — | |
Net borrowing of commercial paper | | 287 | | | 322 | |
Net repayment of short-term debt | | (9) | | | (44) | |
Repayment of lease liabilities | | (6) | | | (6) | |
Share buybacks/cancellations | | — | | | (30) | |
Dividends paid | | (366) | | | (361) | |
| | | | |
Net cash used in financing activities | | (143) | | | (191) | |
| | | | |
Effect of exchange rates on cash and cash equivalents | | (25) | | | (40) | |
| | | | |
| | | | |
Net decrease in cash and cash equivalents | | (143) | | | (259) | |
Cash and cash equivalents balance at beginning of year | | 588 | | | 689 | |
| | | | |
Cash and cash equivalents balance at end of period | | $ | 445 | | | $ | 430 | |
| | | | |
| | | | |
Supplemental cash flow information: | | | | |
Interest paid, net of amounts capitalized | | $ | 140 | | | $ | 162 | |
Income taxes paid | | $ | 127 | | | $ | 124 | |
| | | | |
Supplemental non-cash disclosures relating to investing and financing activities: | | | | |
Purchase of property, plant, and equipment, accrued but unpaid | | $ | 68 | | | $ | 59 | |
Contingent purchase considerations related to acquired businesses, accrued but not paid | | $ | 15 | | | $ | 27 | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
See accompanying notes to condensed consolidated financial statements.
Amcor plc and Subsidiaries
Condensed Consolidated Statements of Equity
(Unaudited) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
($ in millions, except per share data) | | Ordinary Shares | | Additional Paid-In Capital | | Retained Earnings | | Accumulated Other Comprehensive Loss | | Treasury Shares | | Non-controlling Interests | | Total |
Balance as of September 30, 2023 | | $ | 14 | | | $ | 3,983 | | | $ | 841 | | | $ | (928) | | | $ | (12) | | | $ | 66 | | | $ | 3,964 | |
Net income | | | | | | 134 | | | | | | | 2 | | | 136 | |
Other comprehensive income | | | | | | | | 101 | | | | | — | | | 101 | |
| | | | | | | | | | | | | | |
Dividends declared ($0.125 per share) | | | | | | (180) | | | | | | | (5) | | | (185) | |
Shares vested | | | | (4) | | | | | | | 4 | | | | | — | |
Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax | | | | 3 | | | | | | | | | | | 3 | |
Purchase of treasury shares | | | | | | | | | | (3) | | | | | (3) | |
| | | | | | | | | | | | | | |
Share-based compensation expense | | | | 11 | | | | | | | | | | | 11 | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Balance as of December 31, 2023 | | $ | 14 | | | $ | 3,993 | | | $ | 795 | | | $ | (827) | | | $ | (11) | | | $ | 63 | | | $ | 4,027 | |
| | | | | | | | | | | | | | |
Balance as of June 30, 2023 | | $ | 14 | | | $ | 4,021 | | | $ | 865 | | | $ | (862) | | | $ | (12) | | | $ | 64 | | | $ | 4,090 | |
Net income | | | | | | 286 | | | | | | | 4 | | | 290 | |
Other comprehensive income | | | | | | | | 35 | | | | | — | | | 35 | |
Share buyback/cancellations | | — | | | (30) | | | | | | | | | | | (30) | |
Dividends declared ($0.2475 per share) | | | | | | (356) | | | | | | | (5) | | | (361) | |
Shares vested and related tax withholdings | | | | (52) | | | | | | | 49 | | | | | (3) | |
Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax | | | | 48 | | | | | | | | | | | 48 | |
Purchase of treasury shares | | | | | | | | | | (48) | | | | | (48) | |
| | | | | | | | | | | | | | |
Share-based compensation expense | | | | 6 | | | | | | | | | | | 6 | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Balance as of December 31, 2023 | | $ | 14 | | | $ | 3,993 | | | $ | 795 | | | $ | (827) | | | $ | (11) | | | $ | 63 | | | $ | 4,027 | |
| | | | | | | | | | | | | | |
Balance as of September 30, 2024 | | $ | 14 | | | $ | 4,030 | | | $ | 890 | | | $ | (1,006) | | | $ | (9) | | | $ | 74 | | | $ | 3,993 | |
Net income | | | | | | 163 | | | | | | | 4 | | | 167 | |
Other comprehensive loss | | | | | | | | (128) | | | | | — | | | (128) | |
| | | | | | | | | | | | | | |
Dividends declared ($0.1275 per share) | | | | | | (184) | | | | | | | (2) | | | (186) | |
Options exercised and shares vested, and related tax withholdings | | | | (2) | | | | | | | 3 | | | | | 1 | |
Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax | | | | 4 | | | | | | | | | | | 4 | |
Purchase of treasury shares | | | | | | | | | | (4) | | | | | (4) | |
Share-based compensation expense | | | | 13 | | | | | | | | | | | 13 | |
Change in non-controlling interests | | | | | | | | | | | | (69) | | | (69) | |
| | | | | | | | | | | | | | |
Balance as of December 31, 2024 | | $ | 14 | | | $ | 4,045 | | | $ | 869 | | | $ | (1,134) | | | $ | (10) | | | $ | 7 | | | $ | 3,791 | |
| | | | | | | | | | | | | | |
Balance as of June 30, 2024 | | $ | 14 | | | $ | 4,019 | | | $ | 879 | | | $ | (1,020) | | | $ | (11) | | | $ | 72 | | | $ | 3,953 | |
Net income | | | | | | 354 | | | | | | | 6 | | | 360 | |
Other comprehensive loss | | | | | | | | (114) | | | | | — | | | (114) | |
| | | | | | | | | | | | | | |
Dividends declared ($0.2525 per share) | | | | | | (364) | | | | | | | (2) | | | (366) | |
Options exercised and shares vested, and related tax withholdings | | | | (39) | | | | | | | 48 | | | | | 9 | |
Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax | | | | 47 | | | | | | | | | | | 47 | |
Purchase of treasury shares | | | | | | | | | | (47) | | | | | (47) | |
Share-based compensation expense | | | | 18 | | | | | | | | | | | 18 | |
Change in non-controlling interests | | | | | | | | | | | | (69) | | | (69) | |
| | | | | | | | | | | | | | |
Balance as of December 31, 2024 | | $ | 14 | | | $ | 4,045 | | | $ | 869 | | | $ | (1,134) | | | $ | (10) | | | $ | 7 | | | $ | 3,791 | |
See accompanying notes to condensed consolidated financial statements.
Amcor plc and Subsidiaries
Notes to Condensed Consolidated Financial Statements
Note 1 - Nature of Operations and Basis of Presentation
Amcor plc ("Amcor" or the "Company") is a public limited company incorporated under the Laws of the Bailiwick of Jersey. The Company's history dates back more than 150 years, with origins in both Australia and the United States of America. Today, Amcor is a global leader in developing and producing responsible packaging solutions across a variety of materials for food, beverage, pharmaceutical, medical, home and personal-care, and other consumer goods end markets. The Company's innovation excellence and global packaging expertise enable the Company to solve packaging challenges around the world every day, producing a range of flexible packaging, rigid packaging, cartons, and closures that are more functional, appealing, and cost effective for its customers and their consumers and importantly, more sustainable for the environment.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information. Consistent with these requirements, this Form 10-Q does not include all the information required by U.S. GAAP for complete financial statements. Further, the year-end condensed consolidated balance sheet data as of June 30, 2024, was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. It is management's opinion, however, that all material and recurring adjustments have been made that are necessary for a fair statement of the Company's interim financial position, results of operations, and cash flows. This Form 10-Q should be read in conjunction with the audited consolidated financial statements and accompanying notes in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
There have been no material changes to the accounting policies followed by the Company during the current fiscal year to date. Certain amounts in the Company's notes to unaudited condensed consolidated financial statements may not add or recalculate due to rounding.
Note 2 - New Accounting Guidance
Recently Adopted Accounting Standards
In September 2022, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2022-04 that adds certain disclosure requirements for entities that use supplier finance programs in connection with the purchase of goods and services. The Company adopted the disclosure requirements in ASU 2022-04 on July 1, 2023, except for the amendment on roll forward information which will be adopted, on a prospective basis, in the Company's fiscal year 2025 Annual Report on Form 10-K.
Accounting Standards Not Yet Adopted
In November 2023, the FASB issued ASU 2023-07 that adds new reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses that are regularly provided to the chief operating decision maker and included within segment profit or loss. The ASU becomes effective for the Company beginning with its fiscal year ending June 30, 2025, and interim periods beginning with the first quarter of fiscal year 2026. The Company is currently evaluating the impact that this guidance will have on its disclosures.
In December 2023, the FASB issued ASU 2023-09 that adds new income tax disclosure requirements, primarily related to existing income tax rate reconciliation and income taxes paid information. The standard's amendments are effective for the Company for annual periods beginning July 1, 2025, with early adoption permitted, and can be applied either prospectively or retrospectively. The Company is currently evaluating the impact that this guidance will have on its disclosures.
In November 2024, the FASB issued ASU 2024-03 that requires companies to disclose disaggregated information about certain income statement expense line items. The ASU becomes effective for the Company for annual periods beginning July 1, 2027, and interim reporting periods beginning with the first quarter of fiscal year 2029, with early adoption permitted. The Company is currently evaluating the impact that this guidance will have on its disclosures.
The Company considers the applicability and impact of all ASUs issued by the FASB. The Company determined at this time that all other ASUs not yet adopted are either not applicable or are expected to have an immaterial impact on the Company's consolidated financial statements.
Note 3 - Pending Merger with Berry Global Group, Inc.
On November 19, 2024, the Company, Aurora Spirit, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub”), and Berry Global Group, Inc., a Delaware corporation (“Berry”), entered into an Agreement and Plan of Merger (the “Merger Agreement”). The Merger Agreement provides for, among other things and subject to the satisfaction or waiver of specified conditions set forth therein, the merger of Merger Sub with and into Berry (the “Merger”), with Berry surviving the Merger as a wholly-owned subsidiary of Amcor. The board of directors of Amcor (the “Amcor Board”) and the board of directors of Berry (the “Berry Board”) have unanimously approved the Merger Agreement and the transactions contemplated thereby.
Subject to the terms and conditions set forth in the Merger Agreement, at the effective time of the Merger (the “Effective Time”), each share of Berry common stock issued and outstanding (excluding shares held by Berry as treasury stock immediately prior to the Effective Time) will be converted into the right to receive 7.25 fully paid and nonassessable Amcor ordinary shares (and, if applicable, cash in lieu of fractional shares), less any applicable withholding taxes.
Completion of the Merger is subject to the satisfaction or waiver of certain closing conditions, including, among other things: (1) the adoption of the Merger Agreement by the shareholders of Berry, (2) the approval of the issuance of Amcor ordinary shares in the Merger by Amcor shareholders, and (3) receipt of applicable regulatory approvals.
Both Amcor and Berry have termination rights under the Merger Agreement. Amcor will be required to pay Berry a termination fee equal to $260 million in specified circumstances, including if Amcor terminates the Merger Agreement to enter into a superior proposal or if Berry terminates the Merger Agreement following a change of recommendation by the Amcor Board, in each case, subject to the terms and conditions of the Merger Agreement. Berry will be required to pay Amcor a termination fee equal to $260 million in specified circumstances, including if Berry terminates the Merger Agreement to enter into a superior proposal or if Amcor terminates the Merger Agreement following a change of recommendation by the Berry Board, in each case, subject to the terms and conditions of the Merger Agreement.
Note 4 - Acquisitions and Disposals
Fiscal Year 2024 - Acquisition
On September 27, 2023, the Company completed the acquisition of a small manufacturer of flexible packaging for food, home care, and personal care applications in India for purchase consideration of $14 million plus the assumption of debt of $10 million. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of goodwill of $12 million. Goodwill is not deductible for tax purposes.
The fair value estimates for the acquisition were based on market, and cost valuation methods. Pro forma information related to the acquisition has not been presented, as the effect of the acquisition on the Company's condensed consolidated financial statements was not material.
Fiscal year 2025 - Disposals
On November 25, 2024, the Company completed the sale of a non-core business in France in the Flexibles reportable segment, recording a pre-tax net loss on sale of $7 million which includes a $4 million impairment charge recorded in the first quarter of fiscal year 2025. The loss has been recorded as other income/(expenses), net within the unaudited condensed consolidated statements of income.
On December 27, 2024, the Company completed the sale of its 50% equity interest in the Bericap North America closures business ("Bericap"), which was fully consolidated under the Rigid Packaging reportable segment, for cash consideration of $123 million. The sale resulted in a pre-tax net gain of $15 million which was recorded as other income/(expenses), net, within the unaudited condensed consolidated statements of income. The proceeds from the sale were used to reduce the Company's debt.
Note 5 - Restructuring and Other Activities, Net
Restructuring and other activities, net, as reported on the unaudited condensed consolidated statements of income are summarized as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended December 31, | | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 | | 2024 | | 2023 |
Transaction costs | | $ | (10) | | | $ | — | | | $ | (10) | | | $ | — | |
Restructuring and related expenses, net | | (23) | | | (24) | | | (29) | | | (52) | |
Restructuring and other activities, net | | $ | (33) | | | $ | (24) | | | $ | (39) | | | $ | (52) | |
Transaction costs include incremental costs incurred in connection with the Merger. Refer to Note 3, "Pending Merger with Berry Global Group, Inc."
Refer to Note 6, "Restructuring" for information on restructuring and related expenses, net.
Note 6 - Restructuring
Restructuring and related expenses, net, were $23 million and $24 million during the three months ended December 31, 2024, and 2023, respectively, and $29 million and $52 million during the six months ended December 31, 2024 and 2023, respectively. The Company's restructuring activities for the three and six months ended December 31, 2024, and 2023, were primarily comprised of restructuring activities related to the 2023 Restructuring Plan (as defined below).
Restructuring related expenses are directly attributable to restructuring activities; however, they do not qualify for special accounting treatment as exit or disposal activities. The Company believes the disclosure of restructuring related costs provides more complete information on its restructuring activities.
2023 Restructuring Plan
On February 7, 2023, the Company announced that it will allocate approximately $110 million to $130 million of the sale proceeds from the Russian business to various cost saving initiatives to partly offset divested earnings from the Russian business (the "2023 Restructuring Plan" or the "Plan"). The Company expects total Plan cash and non-cash net expenses of approximately $220 million, of which approximately $100 million relates to employee related expenses, approximately $30 million to fixed asset related expenses (net of expected gains on asset disposals), approximately $55 million to other restructuring expenses, and approximately $35 million to restructuring related expenses. The projects initiated as of December 31, 2024 are expected to result in approximately $130 million of net cash expenditures. The Plan includes both the Flexibles and Rigid Packaging reportable segments and has been largely completed as of December 31, 2024.
From the initiation of the Plan through December 31, 2024, the Company has incurred $99 million in employee related expenses, $33 million in fixed asset related expenses, $52 million in other restructuring, and $24 million in restructuring related expenses, with $182 million incurred in the Flexibles reportable segment and $26 million incurred in the Rigid Packaging reportable segment. The Plan has resulted in cumulative net cash outflows of $96 million. Additional cash payments of approximately $34 million, net of estimated proceeds from disposals, are expected until completion of the Plan, which predominantly relates to the Flexibles reportable segment.
The restructuring related costs relate primarily to the closure of facilities and include startup and training costs after relocation of equipment, and other costs incidental to the Plan.
Other Restructuring Plans
The Company has entered into other individually immaterial restructuring plans ("Other Restructuring Plans"). Expenses incurred on such programs are primarily costs to move equipment and other costs.
Consolidated Restructuring Plans
The total costs incurred from the beginning of the Company's 2023 Restructuring Plan and Other Restructuring Plans are as follows:
| | | | | | | | | | | | | | | | | | | | |
($ in millions) | | 2023 Restructuring Plan (1) | | Other Restructuring Plans (2) | | Total Restructuring and Related Expenses |
Fiscal year 2023 | | $ | 94 | | | $ | 17 | | | $ | 111 | |
Fiscal year 2024 | | 87 | | | 10 | | | 97 | |
Fiscal year 2025, first quarter | | 6 | | | — | | | 6 | |
Fiscal year 2025, second quarter | | 21 | | | 2 | | | 23 | |
| | | | | | |
Net expenses incurred | | $ | 208 | | | $ | 29 | | | $ | 237 | |
(1)Includes restructuring related expenses from the 2023 Restructuring Plan of $6 million, $15 million, $2 million, and $1 million for fiscal year 2023, fiscal year 2024, first quarter of fiscal year 2025, and second quarter of fiscal year 2025 respectively. In the three and six months ended December 31, 2024, $1 million of the restructuring and related expenses, net, were incurred in the Rigid Packaging reportable segment and the remainder in the Flexibles reportable segment.
(2)Includes restructuring related costs of $4 million in both fiscal years 2023 and 2024, and $1 million in the second quarter of fiscal year 2025.
An analysis of the restructuring charges by type incurred is as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended December 31, | | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 | | 2024 | | 2023 |
Employee related expenses | | $ | 18 | | | $ | (3) | | | $ | 18 | | | $ | 13 | |
Fixed asset related expenses | | 1 | | | 6 | | | 2 | | | 12 | |
Other expenses | | 2 | | | 16 | | | 5 | | | 19 | |
Total restructuring expenses, net | | $ | 21 | | | $ | 19 | | | $ | 25 | | | $ | 44 | |
An analysis of the Company's restructuring plan liability is as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
($ in millions) | | Employee Costs | | Fixed Asset Related Costs | | Other Costs | | Total Restructuring Costs |
Liability balance as of June 30, 2024 | | $ | 80 | | | $ | 3 | | | $ | 19 | | | $ | 102 | |
Net charges to earnings | | 18 | | | 2 | | | 5 | | | 25 | |
| | | | | | | | |
Cash paid | | (15) | | | (3) | | | (19) | | | (37) | |
Non-cash and other | | — | | | (2) | | | — | | | (2) | |
Foreign currency translation | | (2) | | | — | | | — | | | (2) | |
Liability balance as of December 31, 2024 | | $ | 81 | | | $ | — | | | $ | 5 | | | $ | 86 | |
The table above includes liabilities arising from the 2023 Restructuring Plan and Other Restructuring Plans. The majority of the accruals related to restructuring activities have been recorded on the unaudited condensed consolidated balance sheets under other current liabilities.
Note 7 - Supply Chain Financing Arrangements
The Company facilitates several regional voluntary supply chain financing ("SCF") programs with financial institutions, all of which have similar characteristics. The Company establishes these SCF programs to provide its suppliers with a potential source of liquidity and to enable a more efficient payment process. Under these SCF programs, qualifying suppliers may elect, but are not obligated, to sell their receivables due from Amcor to these financial institutions in advance of the agreed payment due date. The Company is not involved in negotiations between the suppliers and the financial institutions, and its rights and obligations to its suppliers are not impacted by its suppliers’ decisions to sell amounts to the financial institutions. Under these SCF programs, the Company agrees to pay the financial institution the stated invoice amounts from its participating suppliers on the original maturity dates of the invoices. The range of payment terms negotiated with suppliers under these arrangements are consistent with industry norms and short-term in nature, regardless of whether a supplier participates in the program. The Company's SCF programs do not include any guarantees to the financial institutions, or any assets pledged as securities.
All outstanding amounts related to suppliers participating in the SCF programs are reflected in trade payables in the Company’s unaudited condensed consolidated balance sheets, and associated payments are included in operating activities within the Company’s unaudited condensed consolidated statements of cash flows. As of December 31, 2024, and June 30, 2024, the amounts due to suppliers participating in the Company’s SCF programs amounted to $0.8 billion and $1.1 billion, respectively.
Note 8 - Goodwill and Other Intangible Assets, Net
Goodwill
Changes in the carrying amount of goodwill attributable to each reportable segment were as follows:
| | | | | | | | | | | | | | | | | | | | |
($ in millions) | | Flexibles Segment | | Rigid Packaging Segment | | Total |
Balance as of June 30, 2024 | | $ | 4,373 | | | $ | 972 | | | $ | 5,345 | |
| | | | | | |
Disposals (1) | | (1) | | | (30) | | | (31) | |
Foreign currency translation | | (37) | | | (4) | | | (41) | |
Balance as of December 31, 2024 | | $ | 4,335 | | | $ | 938 | | | $ | 5,273 | |
(1)Disposals are detailed in Note 4, "Acquisitions and Disposals".
Goodwill is not amortized but is tested for impairment annually in the fourth quarter of the fiscal year, or during interim periods if events or circumstances arise which indicate that goodwill may be impaired.
Other Intangible Assets, Net
Other intangible assets, net were comprised of the following:
| | | | | | | | | | | | | | | | | | | | |
| | December 31, 2024 |
($ in millions) | | Gross Carrying Amount | | Accumulated Amortization and Impairment (1) | | Net Carrying Amount |
Customer relationships | | $ | 1,993 | | | $ | (853) | | | $ | 1,140 | |
Computer software | | 277 | | | (185) | | | 92 | |
Other | | 336 | | | (251) | | | 85 | |
Total other intangible assets | | $ | 2,606 | | | $ | (1,289) | | | $ | 1,317 | |
| | | | | | | | | | | | | | | | | | | | |
| | June 30, 2024 |
($ in millions) | | Gross Carrying Amount | | Accumulated Amortization and Impairment (1) | | Net Carrying Amount |
Customer relationships | | $ | 1,999 | | | $ | (791) | | | $ | 1,208 | |
Computer software | | 272 | | | (182) | | | 90 | |
Other (2) | | 334 | | | (241) | | | 93 | |
Total other intangible assets | | $ | 2,605 | | | $ | (1,214) | | | $ | 1,391 | |
(1)Accumulated amortization and impairment as of December 31, 2024, and June 30, 2024 included $34 million of accumulated impairment in the Other category.
(2)As of June 30, 2024, Other included $17 million of acquired intellectual property assets not yet being amortized as the related R&D projects had not yet been completed.
Amortization expenses for intangible assets were $42 million and $47 million during the three months ended December 31, 2024 and 2023, respectively, and $84 million and $91 million during the six months ended December 31, 2024 and 2023, respectively.
Note 9 - Fair Value Measurements
The fair values of the Company's financial assets and financial liabilities listed below reflect the amounts that would be received to sell the assets or paid to transfer the liabilities in an orderly transaction between market participants at the measurement date (exit price).
The Company's non-derivative financial instruments primarily include cash and cash equivalents, trade receivables, trade payables, short-term debt, and long-term debt. As of December 31, 2024, and June 30, 2024, the carrying value of these financial instruments, excluding long-term debt, approximated fair value because of the short-term nature of these instruments.
The carrying value of long-term debt with variable interest rates approximates its fair value. The fair value of the Company's long-term debt with fixed interest rates is based on market prices, if available, or expected future cash flows discounted at the current interest rate for financial liabilities with similar risk profiles.
The carrying values and estimated fair values of long-term debt with fixed interest rates were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | December 31, 2024 | | June 30, 2024 |
| | Carrying Value | | Fair Value | | Carrying Value | | Fair Value |
($ in millions) | | | (Level 2) | | | (Level 2) |
Total long-term debt with fixed interest rates (excluding commercial paper (1) and finance leases) | | $ | 5,126 | | | $ | 5,035 | | | $ | 5,141 | | | $ | 4,973 | |
(1)As of December 31, 2024, the Company had interest rate swap contracts outstanding for a total notional amount of commercial paper of $400 million, maturing on June 30, 2025. These contracts are considered to be economic hedges and the related $400 million notional amount of commercial paper is also excluded from the total long-term debt with fixed interest rates.
Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis
Additionally, the Company measures and records certain assets and liabilities, including derivative instruments and contingent purchase consideration liabilities, at fair value. The following tables summarize the fair values of these instruments, which are measured at fair value on a recurring basis, by level, within the fair value hierarchy:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | December 31, 2024 |
($ in millions) | | Level 1 | | Level 2 | | Level 3 | | Total |
Assets | | | | | | | | |
Commodity contracts | | $ | — | | | $ | 3 | | | $ | — | | | $ | 3 | |
Forward exchange contracts | | — | | | 5 | | | — | | | 5 | |
| | | | | | | | |
| | | | | | | | |
Total assets measured at fair value | | $ | — | | | $ | 8 | | | $ | — | | | $ | 8 | |
| | | | | | | | |
Liabilities | | | | | | | | |
Contingent purchase consideration | | $ | — | | | $ | — | | | $ | 25 | | | $ | 25 | |
Commodity contracts | | — | | | 1 | | | — | | | 1 | |
Forward exchange contracts | | — | | | 8 | | | — | | | 8 | |
Interest rate swaps | | — | | | 86 | | | — | | | 86 | |
Cross currency swaps | | — | | | 23 | | | — | | | 23 | |
Total liabilities measured at fair value | | $ | — | | | $ | 118 | | | $ | 25 | | | $ | 143 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | June 30, 2024 |
($ in millions) | | Level 1 | | Level 2 | | Level 3 | | Total |
Assets | | | | | | | | |
Commodity contracts | | $ | — | | | $ | 2 | | | $ | — | | | $ | 2 | |
Forward exchange contracts | | — | | | 2 | | | — | | | 2 | |
| | | | | | | | |
Total assets measured at fair value | | $ | — | | | $ | 4 | | | $ | — | | | $ | 4 | |
| | | | | | | | |
Liabilities | | | | | | | | |
Contingent purchase consideration | | $ | — | | | $ | — | | | $ | 36 | | | $ | 36 | |
Commodity contracts | | — | | | 1 | | | — | | | 1 | |
Forward exchange contracts | | — | | | 4 | | | — | | | 4 | |
Interest rate swaps | | — | | | 92 | | | — | | | 92 | |
Cross currency swaps | | — | | | 16 | | | — | | | 16 | |
Total liabilities measured at fair value | | $ | — | | | $ | 113 | | | $ | 36 | | | $ | 149 | |
The fair value of the commodity contracts was determined using a discounted cash flow analysis based on the terms of the contracts and observed market forward prices discounted at a currency specific rate. Forward exchange contract fair values were determined based on quoted prices for similar assets and liabilities in active markets using inputs such as currency rates and forward points. The fair value of the interest rate swaps was determined using a discounted cash flow method based on market-based swap yield curves, taking into account current interest rates.
Contingent purchase consideration liabilities arise from business acquisitions and other investments. As of December 31, 2024, the Company had contingent purchase consideration liabilities of $25 million, consisting of $15 million of contingent purchase consideration predominantly relating to fiscal year 2023 acquisitions and a $10 million liability that is contingent on future royalty income generated by Discma AG, a subsidiary acquired in March 2017. The fair values of the contingent purchase consideration liabilities were determined for each arrangement individually. The fair values were determined using an income approach with significant inputs that are not observable in the market. Key assumptions include the selection of discount rates consistent with the level of risk of achievement and probability-adjusted financial projections. The expected outcomes are recorded at net present value, which require adjustment over the life for changes in risks and probabilities. Changes arising from modifications in forecasts related to contingent consideration are not expected to be material.
The fair value of contingent purchase consideration liabilities is included in other current liabilities and other non-current liabilities in the unaudited condensed consolidated balance sheets.
Assets and Liabilities Measured and Recorded at Fair Value on a Nonrecurring Basis
In addition to assets and liabilities that are recorded at fair value on a recurring basis, the Company records certain assets at fair value on a nonrecurring basis, generally when events or changes in circumstances indicate the carrying value may not be recoverable, or when they are deemed to be other than temporarily impaired. These assets include goodwill and other intangible assets, equity method and other investments, long-lived assets and disposal groups held for sale, and other long-lived assets. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges or as a result of charges to remeasure assets classified as held for sale to fair value less costs to sell. The fair values of these assets are determined, when applicable, based on valuation techniques using the best information available, and may include quoted market prices, market comparables, and discounted cash flow projections. These nonrecurring fair value measurements are considered to be Level 3 in the fair value hierarchy.
In the first quarter of fiscal year 2025, the Company recorded an impairment charge of $4 million within the Flexibles reportable segment, to adjust the carrying value of the net assets of $11 million that were held for sale to their estimated fair value less cost to sell. The Company completed the sale of these non-core assets in the three months ended December 31, 2024. Refer to Note 4, "Acquisitions and Disposals".
During the three months ended December 31, 2024, and 2023, there were no impairment charges recorded on indefinite-lived intangibles, including goodwill. For information on long-lived asset impairments, refer to fixed asset related expenses in Note 6, "Restructuring".
Note 10 - Derivative Instruments
The Company periodically uses derivatives and other financial instruments to hedge exposures to interest rates, commodity prices, and currency risks. The Company does not hold or issue derivative instruments for speculative or trading purposes. For hedges that meet hedge accounting criteria, the Company, at inception, formally designates and documents the instruments as a fair value hedge or a cash flow hedge of a specific underlying exposure. On an ongoing basis, the Company assesses and documents that its designated hedges have been and are expected to continue to be highly effective.
Interest Rate Risk
The Company's policy is to manage exposure to interest rate risk by maintaining a mixture of fixed-rate and variable-rate debt, monitoring global interest rates, and, where appropriate, hedging floating interest rate exposure or debt at fixed interest rates through various interest rate derivative instruments including, but not limited to, interest rate swaps, and interest rate locks. For interest rate swaps that are accounted for as fair value hedges, the gains and losses related to the changes in the fair value of the interest rate swaps are included in interest expense and offset changes in the fair value of the hedged portion of the underlying debt that are attributable to the changes in market interest rates. Changes in the fair value of interest rate swaps that have not been designated as hedging instruments are reported in the accompanying unaudited condensed consolidated statements of income in other income/(expenses), net.
On August 5, 2024, the Company entered into an interest rate swap contract for a notional amount of $500 million, which was subsequently downsized to $400 million notional on November 4, 2024. Under the terms of the contract, the Company pays a fixed rate of interest of 4.30% and receives a variable rate of interest, based on compound overnight Secured Overnight Financing Rate ("SOFR"), effective from August 12, 2024, through June 30, 2025, with monthly settlements commencing on September 1, 2024. The interest rate swap contract will economically hedge the SOFR component of the Company's forecasted commercial paper issuances. As of December 31, 2024, the Company had no other receive-variable/pay-fixed interest rate swaps outstanding. As of June 30, 2024, the Company did not have receive-variable, pay-fixed interest rate swaps outstanding. The Company did not apply hedge accounting on these economic hedging instruments.
As of December 31, 2024, and June 30, 2024, the total notional amount of the Company’s receive-fixed/pay-variable interest rate swaps was $650 million.
Foreign Currency Risk
The Company manufactures and sells its products and finances operations in a number of countries throughout the world and, as a result, is exposed to movements in foreign currency exchange rates. The purpose of the Company's foreign currency hedging program is to manage the volatility associated with the changes in exchange rates.
To manage this exchange rate risk, the Company utilizes forward contracts and cross currency swaps. Forward contracts that qualify for hedge accounting are designated as cash flow hedges of certain forecasted transactions denominated in foreign currencies. The effective portion of the changes in fair value of these instruments is reported in accumulated other comprehensive loss ("AOCI") and reclassified into earnings in the same financial statement line item and in the same period or periods during which the related hedged transactions affect earnings. The ineffective portion is recognized in earnings over the life of the hedging relationship in the same consolidated statements of income line item as the underlying hedged item. Changes in the fair value of forward contracts that have not been designated as hedging instruments are reported in the accompanying unaudited condensed consolidated statements of income.
As of December 31, 2024, and June 30, 2024, the notional amounts of the outstanding forward contracts were $613 million and $556 million, respectively.
In May 2024, the Company entered into cross currency swap contracts for a total notional amount of $500 million. Under the terms of the contracts, the Company swapped the U.S. dollar notional and periodic interest payments to Swiss francs to manage foreign currency risk and receives a fixed U.S. dollar rate of interest of 5.450% and pays a fixed weighted-average Swiss franc rate of interest of 2.218%. The Company has designated these cross currency swap contracts as a fair value hedge of its $500 million notes and recognizes the components excluded from the hedging relationship in accumulated other comprehensive loss ("AOCI") and reclassifies into earnings through the accrual of the periodic interest settlements on the swaps.
At December 31, 2024 and June 30, 2024, the Company had cross currency swaps with a notional amount of $500 million outstanding.
Commodity Risk
Certain raw materials used in the Company's production processes are subject to price volatility caused by weather, supply conditions, political and economic variables, and other unpredictable factors. The Company's policy is to minimize exposure to price volatility by passing through the commodity price risk to customers, including through the use of fixed price swaps.
In some cases, the Company purchases, on behalf of customers, fixed price commodity swaps to offset the exposure of price volatility on the underlying sales contracts. These instruments are cash closed out on maturity and the related cost or benefit is passed through to customers. Information about commodity price exposure is derived from supply forecasts submitted by customers and these exposures are hedged by central treasury units. Changes in the fair value of commodity hedges are recognized in AOCI. The cumulative amount of the hedge is recognized in the unaudited condensed consolidated statements of income when the forecasted transaction is realized.
The Company had the following outstanding commodity contracts to hedge forecasted purchases:
| | | | | | | | | | | | | | |
| | December 31, 2024 | | June 30, 2024 |
Commodity | | Volume | | Volume |
Aluminum | | 19,293 tons | | 10,673 tons |
PET resin | | 24,722,727 lbs. | | 27,916,666 lbs. |
The following table provides the location of derivative instruments in the unaudited condensed consolidated balance sheets:
| | | | | | | | | | | | | | | | | | | | |
($ in millions) | | Balance Sheet Location | | December 31, 2024 | | June 30, 2024 |
Assets | | | | | | |
Derivatives in cash flow hedging relationships: | | | | | | |
Commodity contracts | | Other current assets | | $ | 3 | | | $ | 2 | |
Forward exchange contracts | | Other current assets | | 5 | | | 2 | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
Total current derivative contracts | | | | 8 | | | 4 | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
Total non-current derivative contracts | | | | — | | | — | |
Total derivative asset contracts | | | | $ | 8 | | | $ | 4 | |
| | | | | | |
Liabilities | | | | | | |
Derivatives in cash flow hedging relationships: | | | | | | |
Commodity contracts | | Other current liabilities | | $ | 1 | | | $ | 1 | |
Forward exchange contracts | | Other current liabilities | | 6 | | | 3 | |
| | | | | | |
Derivatives not designated as hedging instruments: | | | | | | |
Forward exchange contracts | | Other current liabilities | | 2 | | | 1 | |
| | | | | | |
Total current derivative contracts | | | | 9 | | | 5 | |
| | | | | | |
| | | | | | |
Derivatives in fair value hedging relationships: | | | | | | |
Interest rate swaps | | Other non-current liabilities | | 86 | | | 92 | |
Cross currency swaps | | Other non-current liabilities | | 23 | | | 16 | |
| | | | | | |
| | | | | | |
Total non-current derivative contracts | | | | 109 | | | 108 | |
Total derivative liability contracts | | | | $ | 118 | | | $ | 113 | |
Certain derivative financial instruments are subject to master netting arrangements and are eligible for offset. The Company has made an accounting policy election not to offset the fair values of these instruments within the unaudited condensed consolidated balance sheets.
The following tables provide the effects of derivative instruments on AOCI and in the unaudited condensed consolidated statements of income:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Location of Loss Reclassified from AOCI into Income | | Loss Reclassified from AOCI into Income (Effective Portion) |
| | | Three Months Ended December 31, | | Six Months Ended December 31, |
($ in millions) | | | 2024 | | 2023 | | 2024 | | 2023 |
Derivatives in cash flow hedging relationships | | | | | | | | | | |
Commodity contracts | | Cost of sales | | $ | (1) | | | $ | — | | | $ | — | | | $ | (1) | |
Forward exchange contracts | | Net sales | | — | | | (1) | | | — | | | — | |
| | | | | | | | | | |
Treasury locks | | Interest expense | | — | | | — | | | (1) | | | (1) | |
Total | | | | $ | (1) | | | $ | (1) | | | $ | (1) | | | $ | (2) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Location of Gain / (Loss) Recognized in the Unaudited Condensed Consolidated Statements of Income | | Gain / (Loss) Recognized in Income for Derivatives Not Designated as Hedging Instruments |
| | | Three Months Ended December 31, | | Six Months Ended December 31, |
($ in millions) | | | 2024 | | 2023 | | 2024 | | 2023 |
Derivatives not designated as hedging instruments | | | | | | | | | | |
Forward exchange contracts | | Other income/(expenses), net | | $ | (2) | | | $ | 6 | | | $ | (2) | | | $ | 8 | |
Interest rate swaps | | Other income/(expenses), net | | 1 | | | (6) | | | — | | | (9) | |
Total | | | | $ | (1) | | | $ | — | | | $ | (2) | | | $ | (1) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Location of Gain / (Loss) Recognized in the Unaudited Condensed Consolidated Statements of Income | | Gain / (Loss) Recognized in Income for Derivatives in Fair Value Hedging Relationships |
| | | Three Months Ended December 31, | | Six Months Ended December 31, |
($ in millions) | | | 2024 | | 2023 | | 2024 | | 2023 |
Derivatives in fair value hedging relationships | | | | | | | | | | |
Interest rate swaps | | Interest expense | | $ | (19) | | | $ | 25 | | | $ | 6 | | | $ | 14 | |
Cross currency swaps (1) | | Interest expense | | 4 | | | — | | | 7 | | — | |
Cross currency swaps | | Other income/(expenses), net | | 38 | | | — | | | 3 | | — | |
| | | | | | | | | | |
Total | | | | $ | 23 | | | $ | 25 | | | $ | 16 | | | $ | 14 | |
(1)Represents the gains for amounts excluded from the effectiveness testing.
Note 11 - Components of Net Periodic Benefit Cost
Net periodic benefit cost for defined benefit plans included the following components:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended December 31, | | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 | | 2024 | | 2023 |
Service cost | | $ | 3 | | | $ | 5 | | | $ | 7 | | | $ | 9 | |
Interest cost | | 13 | | | 12 | | | 26 | | | 25 | |
Expected return on plan assets | | (13) | | | (14) | | | (26) | | | (28) | |
Amortization of actuarial loss | | 2 | | | 1 | | | 3 | | | 2 | |
Amortization of prior service credit | | (1) | | | (1) | | | (2) | | | (2) | |
| | | | | | | | |
Settlement costs | | 1 | | | — | | | 1 | | | 1 | |
Net periodic benefit cost | | $ | 5 | | | $ | 3 | | | $ | 9 | | | $ | 7 | |
Service cost is included in operating income. All other components of net periodic benefit cost are recorded within other non-operating income/(expenses), net.
Settlement costs for the three months ended December 31, 2024, relate to payments made to certain eligible active and terminated vested participants, in one of the Company's closed principal funded defined benefit plans in the United States (the "U.S. Plan"), who opted to receive a lump-sum payment. The settlement reduced both the projected benefit obligation and fair value of plan assets of the U.S. Plan by $27 million and resulted in a non-cash settlement charge of approximately $2 million related to the accelerated recognition of unamortized net actuarial losses in accumulated other comprehensive loss. This loss was partially offset by a non-cash settlement gain of approximately $1 million following the sale of Bericap.
Note 12 - Debt
In connection with the contemplated Merger (refer to Note 3, "Pending Merger with Berry Global Group, Inc."), the Company entered into a commitment letter with lending institutions, dated as of November 19, 2024, to provide a 364-day senior unsecured bridge loan facility (the "Bridge Facility") in an aggregate principal amount of up to $3.0 billion to fund the repayment of certain outstanding debt of Berry upon the closing of the Merger, and the payment of fees and expenses related to the Merger. The Company paid a commitment fee of $11 million on the Bridge Facility in the three months ended December 31, 2024. The principal amount will be available in a single drawing on the closing date of the Merger. The Bridge Facility is subject to customary terms and conditions.
As of December 31, 2024, the Company had not converted the commitment into a Bridge Facility and therefore there were no outstanding borrowings on the Bridge Facility. If the Company obtains additional funding by issuing securities or obtaining other loans, the amount of the Bridge Facility will be correspondingly reduced.
Note 13 - Income Taxes
The provision for income taxes for the three and six months ended December 31, 2024 and 2023 is based on the Company’s estimated annual effective tax rate for the respective fiscal years which is applied on income before income taxes and equity in income/(loss) of affiliated companies, and is adjusted for specific items that are required to be recognized in the period in which they are incurred.
The effective tax rate for the three months ended December 31, 2024, increased by 8.9 percentage points compared to the three months ended December 31, 2023 from 17.0% to 25.9%, primarily due to the tax impact of the divestiture of Bericap in the current period, and differences in the magnitudes of non-deductible expenses and discrete events between the periods.
The effective tax rate for the six months ended December 31, 2024, increased by 3.3 percentage points compared to the six months ended December 31, 2023 from 18.7% to 22.0%, primarily due to the tax impact of the divestiture of Bericap in the current period, and differences in the magnitudes of non-deductible expenses and discrete events between the periods.
Note 14 - Shareholders' Equity
The changes in ordinary and treasury shares during the six months ended December 31, 2024, and 2023 were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Ordinary Shares | | Treasury Shares |
(shares and $ in millions) | | Number of Shares | | Amount | | Number of Shares | | Amount |
Balance as of June 30, 2023 | | 1,448 | | | $ | 14 | | | 1 | | | $ | (12) | |
Share buyback / cancellations | | (3) | | | — | | | — | | | — | |
Shares vested | | — | | | — | | | (4) | | | 49 | |
| | | | | | | | |
Purchase of treasury shares | | — | | | — | | | 4 | | | (48) | |
Balance as of December 31, 2023 | | 1,445 | | | $ | 14 | | | 1 | | | $ | (11) | |
| | | | | | | | |
Balance as of June 30, 2024 | | 1,445 | | | $ | 14 | | | 1 | | | $ | (11) | |
| | | | | | | | |
Options exercised and shares vested | | — | | | — | | | (4) | | | 48 | |
| | | | | | | | |
Purchase of treasury shares | | — | | | — | | | 4 | | | (47) | |
Balance as of December 31, 2024 | | 1,445 | | | $ | 14 | | | 1 | | | $ | (10) | |
The changes in the components of accumulated other comprehensive loss, net of tax, during the six months ended December 31, 2024, and 2023 were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Foreign Currency Translation | | Net Investment Hedge | | Pension | | Effective Derivatives | | Total Accumulated Other Comprehensive Loss |
($ in millions) | | | | | |
Balance as of June 30, 2023 | | $ | (823) | | | $ | (13) | | | $ | (10) | | | $ | (16) | | | $ | (862) | |
Other comprehensive income before reclassifications | | 31 | | | — | | | — | | | 1 | | | 32 | |
Amounts reclassified from accumulated other comprehensive loss | | — | | | — | | | 1 | | | 2 | | | 3 | |
Net current period other comprehensive income | | 31 | | | — | | | 1 | | | 3 | | | 35 | |
Balance as of December 31, 2023 | | $ | (792) | | | $ | (13) | | | $ | (9) | | | $ | (13) | | | $ | (827) | |
| | | | | | | | | | |
Balance as of June 30, 2024 | | $ | (931) | | | $ | (13) | | | $ | (55) | | | $ | (21) | | | $ | (1,020) | |
Other comprehensive loss before reclassifications | | (113) | | | — | | | (4) | | | (8) | | | (125) | |
Amounts reclassified from accumulated other comprehensive loss | | 8 | | | — | | | 2 | | | 1 | | | 11 | |
Net current period other comprehensive loss | | (105) | | | — | | | (2) | | | (7) | | | (114) | |
Balance as of December 31, 2024 | | $ | (1,036) | | | $ | (13) | | | $ | (57) | | | $ | (28) | | | $ | (1,134) | |
The following tables provide details of amounts reclassified from AOCI into income:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended December 31, | | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 | | 2024 | | 2023 |
Amortization of pension: | | | | | | | | |
Amortization of prior service credit | | $ | (1) | | | $ | (1) | | | $ | (2) | | | $ | (2) | |
Amortization of actuarial loss | | 2 | | | 1 | | | 3 | | | 2 | |
Effect of pension settlement | | 1 | | | — | | | 1 | | | 1 | |
Total before tax effect | | 2 | | | — | | | 2 | | | 1 | |
Tax effect | | — | | | — | | | — | | | — | |
Total net of tax | | $ | 2 | | | $ | — | | | $ | 2 | | | $ | 1 | |
| | | | | | | | |
Losses on cash flow hedges: | | | | | | | | |
Commodity contracts | | $ | 1 | | | $ | — | | | $ | — | | | $ | 1 | |
Forward exchange contracts | | — | | | 1 | | | — | | | — | |
Treasury locks | | — | | | — | | | 1 | | | 1 | |
Total before tax effect | | 1 | | | 1 | | | 1 | | | 2 | |
Tax effect | | — | | | — | | | — | | | — | |
Total net of tax | | $ | 1 | | | $ | 1 | | | $ | 1 | | | $ | 2 | |
| | | | | | | | |
Losses on foreign currency translation | | | | | | | | |
Foreign currency translation adjustment | | $ | 8 | | | $ | — | | | $ | 8 | | | $ | — | |
Total before tax effect | | 8 | | | — | | | 8 | | | — | |
Tax effect | | — | | | — | | | — | | | — | |
Total net of tax | | $ | 8 | | | $ | — | | | $ | 8 | | | $ | — | |
Forward contracts to purchase own shares
The Company's employee share plans require the delivery of shares to employees in the future when rights vest or vested options are exercised. The Company currently acquires shares on the open market to deliver shares to employees to satisfy vesting or exercising commitments which exposes the Company to market price risk.
To protect the Company from share price volatility, the Company has entered into forward contracts for the purchase of its ordinary shares. As of December 31, 2024, the Company had forward contracts outstanding that were entered into in September 2022 and mature in March 2025 to purchase 2 million shares at a weighted average price of $12.16. As of June 30, 2024, the Company had forward contracts outstanding that were entered into in September 2022 and matured in September 2024 to purchase 6 million shares at a weighted average price of $12.11. During the six months ended December 31, 2024, the Company settled 4 million shares which related to outstanding forward contracts as of June 30, 2024.
The forward contracts to purchase the Company's own shares have been included in other current liabilities in the unaudited condensed consolidated balance sheets. Equity is reduced by an amount equal to the fair value of the shares at inception. The carrying value of the forward contracts at each reporting period was determined based on the present value of the cost required to settle the contracts.
Note 15 - Segments
The Company's business is organized and presented in the two reportable segments outlined below:
Flexibles: Consists of operations that manufacture flexible and film packaging in the food and beverage, medical and pharmaceutical, fresh produce, snack food, personal care, and other industries.
Rigid Packaging: Consists of operations that manufacture rigid containers for a broad range of predominantly beverage and food products, including carbonated soft drinks, water, juices, sports drinks, milk-based beverages, spirits and wine, sauces, dressings, spreads and personal care items, and plastic caps for a wide variety of applications.
Other consists of the Company's undistributed corporate expenses, including executive and functional compensation costs, equity method and other investments, intercompany eliminations, and other business activities.
The accounting policies of the reportable segments are the same as those in the unaudited condensed consolidated financial statements. Intersegment sales and transfers are not significant.
The following table presents information about reportable segments:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended December 31, | | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 | | 2024 | | 2023 |
| | | | | | | | |
Flexibles | | $ | 2,511 | | | $ | 2,481 | | | $ | 5,062 | | | $ | 5,049 | |
Rigid Packaging | | 730 | | | 770 | | | 1,532 | | | 1,645 | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Net sales | | $ | 3,241 | | | $ | 3,251 | | | $ | 6,594 | | | $ | 6,694 | |
| | | | | | | | |
Adjusted earnings before interest and taxes ("Adjusted EBIT") | | | | | | | | |
Flexibles | | $ | 322 | | | $ | 312 | | | $ | 651 | | | $ | 634 | |
Rigid Packaging | | 53 | | | 51 | | | 115 | | | 113 | |
Other | | (12) | | | (11) | | | (38) | | | (38) | |
Adjusted EBIT | | 363 | | | 352 | | | 728 | | | 709 | |
| | | | | | | | |
| | | | | | | | |
Less: Amortization of acquired intangible assets from business combinations (1) | | (40) | | | (43) | | | (79) | | | (83) | |
| | | | | | | | |
Less: Impact of hyperinflation (2) | | (3) | | | (34) | | | (5) | | | (51) | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Less: Restructuring and related expenses, net (3) | | (23) | | | (24) | | | (29) | | | (52) | |
| | | | | | | | |
Less: Other (4) | | — | | | (9) | | | (7) | | | (13) | |
| | | | | | | | |
| | | | | | | | |
Interest income | | 9 | | | 11 | | | 20 | | | 21 | |
Interest expense | | (81) | | | (89) | | | (167) | | | (174) | |
Equity in (income)/loss of affiliated companies, net of tax | | (1) | | | 1 | | | (1) | | | 2 | |
Income before income taxes and equity in (income)/loss of affiliated companies | | $ | 224 | | | $ | 165 | | | $ | 460 | | | $ | 359 | |
(1)Amortization of acquired intangible assets from business combinations includes amortization expenses related to all acquired intangible assets from past acquisitions.
(2)Impact of hyperinflation includes the adverse impact of highly inflationary accounting for subsidiaries in Argentina where the functional currency was the Argentine Peso.
(3)Restructuring and related expenses, net, primarily includes costs incurred in connection with the 2023 Restructuring Plan. Refer to Note 6 - "Restructuring" for further information.
(4)Other includes, for the three and six months ended December 31, 2024, various expense and income items primarily relating to a pre-tax gain on the disposal Bericap of $15 million, offset by transaction costs related to the announced Merger of $10 million, and a loss on disposal of a non-core business. Refer to Note 3 - "Pending Merger with Berry Global Group, Inc." and Note 4 - "Acquisitions and Disposals" for further information. For the three and six months ended December 31, 2023, Other includes various expense and income items relating to acquisitions, retroactive foil duties, certain litigation reserve settlements, and fair value movements on economic hedges.
The following tables disaggregate net sales by geography in which the Company operates based on manufacturing or selling operations:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended December 31, |
| | 2024 | | 2023 |
($ in millions) | | Flexibles | | Rigid Packaging | | Total | | Flexibles | | Rigid Packaging | | Total |
North America | | $ | 980 | | | $ | 519 | | | $ | 1,499 | | | $ | 951 | | | $ | 549 | | | $ | 1,500 | |
Latin America | | 250 | | | 211 | | | 461 | | | 265 | | | 221 | | | 486 | |
Europe | | 857 | | | — | | | 857 | | | 864 | | | — | | | 864 | |
Asia Pacific | | 424 | | | — | | | 424 | | | 401 | | | — | | | 401 | |
Net sales | | $ | 2,511 | | | $ | 730 | | | $ | 3,241 | | | $ | 2,481 | | | $ | 770 | | | $ | 3,251 | |
| | | | | | | | | | | | |
| | Six Months Ended December 31, |
| | 2024 | | 2023 |
($ in millions) | | Flexibles | | Rigid Packaging | | Total | | Flexibles | | Rigid Packaging | | Total |
North America | | $ | 2,011 | | | $ | 1,124 | | | $ | 3,135 | | | $ | 1,975 | | | $ | 1,225 | | | $ | 3,200 | |
Latin America | | 521 | | | 408 | | | 929 | | | 550 | | | 420 | | | 970 | |
Europe | | 1,695 | | | — | | | 1,695 | | | 1,722 | | | — | | | 1,722 | |
Asia Pacific | | 835 | | | — | | | 835 | | | 802 | | | — | | | 802 | |
Net sales | | $ | 5,062 | | | $ | 1,532 | | | $ | 6,594 | | | $ | 5,049 | | | $ | 1,645 | | | $ | 6,694 | |
Note 16 - Earnings Per Share Computations
The Company applies the two-class method when computing its earnings per share ("EPS"), which requires that net income per share for each class of share be calculated assuming all of the Company's net income is distributed as dividends to each class of share based on their contractual rights.
Basic EPS is computed by dividing net income available to ordinary shareholders by the weighted-average number of ordinary shares outstanding after excluding the ordinary shares to be repurchased using forward contracts. Diluted EPS includes the effects of share options, restricted share units, performance rights, performance shares, and share rights, if dilutive.
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended December 31, | | Six Months Ended December 31, |
(in millions, except per share amounts) | | 2024 | | 2023 | | 2024 | | 2023 |
Numerator | | | | | | | | |
Net income attributable to Amcor plc | | $ | 163 | | | $ | 134 | | | $ | 354 | | | $ | 286 | |
Distributed and undistributed earnings attributable to shares to be repurchased | | — | | | (1) | | | (1) | | | (1) | |
Net income available to ordinary shareholders of Amcor plc—basic and diluted | | $ | 163 | | | $ | 133 | | | $ | 353 | | | $ | 285 | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Denominator | | | | | | | | |
Weighted-average ordinary shares outstanding | | 1,445 | | | 1,444 | | | 1,445 | | | 1,445 | |
Weighted-average ordinary shares to be repurchased by Amcor plc | | (2) | | | (5) | | | (3) | | | (6) | |
Weighted-average ordinary shares outstanding for EPS—basic | | 1,443 | | | 1,439 | | | 1,442 | | | 1,439 | |
Effect of dilutive shares | | 3 | | | 1 | | | 3 | | | 1 | |
Weighted-average ordinary shares outstanding for EPS—diluted | | 1,446 | | | 1,440 | | | 1,445 | | | 1,440 | |
| | | | | | | | |
Per ordinary share income | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Basic earnings per ordinary share | | $ | 0.113 | | | $ | 0.093 | | | $ | 0.245 | | | $ | 0.198 | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Diluted earnings per ordinary share | | $ | 0.113 | | | $ | 0.092 | | | $ | 0.244 | | | $ | 0.198 | |
Note: Per share amounts are computed independently for each of the quarters presented. The sum of the quarters may not equal the total year amount due to the impact of changes in average quarterly shares outstanding and all other quarterly amounts may not equal the total year due to rounding.
Certain stock awards outstanding were not included in the computation of diluted earnings per share above because they would not have had a dilutive effect. The excluded stock awards represented an aggregate of 17 million and 18 million shares for the three and six months ended December 31, 2024, respectively. The excluded stock awards represented an aggregate of 35 million and 31 million shares, for the three and six months ended December 31, 2023, respectively.
Note 17 - Contingencies and Legal Proceedings
Contingencies - Brazil
The Company's operations in Brazil are involved in various governmental assessments and litigation, principally related to claims for excise and income taxes. The Company vigorously defends its positions and believes it will prevail on most, if not all, of these matters. The Company does not believe that the ultimate resolution of these matters will materially impact the Company's consolidated results of operations, financial position, or cash flows. Under customary local regulations, the Company's Brazilian subsidiaries may need to post cash or other collateral if a challenge to any administrative assessment proceeds to the Brazilian court system; however, the level of cash or collateral already pledged or potentially required to be pledged would not significantly impact the Company's liquidity. As of December 31, 2024, the Company has recorded accruals of $11 million, included in other non-current liabilities in the unaudited condensed consolidated balance sheets. The Company has estimated a reasonably possible loss exposure in excess of the recorded accrual of $21 million as of December 31, 2024. The litigation process is subject to many uncertainties and the outcome of individual matters cannot be accurately predicted. The Company routinely assesses these matters as to the probability of ultimately incurring a liability and records the best estimate of the ultimate loss in situations where the likelihood of an ultimate loss is probable. The Company's assessments are based on its knowledge and experience, but the ultimate outcome of any of these matters may differ from the Company's estimates.
As of December 31, 2024, the Company provided letters of credit of $12 million, judicial insurance of $1 million, and deposited cash of $13 million with the courts to continue to defend the cases referenced above.
Contingencies - Environmental Matters
The Company, along with others, has been identified as a potentially responsible party ("PRP") at several waste disposal sites under U.S. federal and related state environmental statutes and regulations and may face potentially material environmental remediation obligations. While the Company benefits from various forms of insurance policies, actual coverage may not, or may only partially, cover the total potential exposures. As of December 31, 2024, the Company has recorded aggregate accruals of $9 million for its share of estimated future remediation costs at these sites.
In addition to the matters described above, as of December 31, 2024, the Company has also recorded aggregate accruals of $37 million for potential liabilities for remediation obligations at various worldwide locations that are owned or operated by the Company, or were formerly owned or operated.
The SEC requires the Company to disclose certain information about proceedings arising under federal, state, or local environmental provisions if the Company reasonably believes that such proceeding may result in monetary sanctions above a stated threshold. Pursuant to SEC regulations, the Company uses a threshold of $1 million or more for purposes of determining whether disclosure of any such proceedings is required. Applying this threshold, there are no environmental matters required to be disclosed for the three and six months ended December 31, 2024.
While the Company believes that its accruals are adequate to cover its future obligations, there can be no assurance that the ultimate payments will not exceed the accrued amounts. Nevertheless, based on the available information, the Company does not believe that its potential environmental obligations will have a material adverse effect upon its liquidity, results of operations, or financial condition.
Other Matters
In the normal course of business, the Company is subject to legal proceedings, lawsuits, and other claims. While the potential financial impact with respect to these ordinary course matters is subject to many factors and uncertainties, management believes that any financial impact to the Company from these matters, individually and in the aggregate, would not have a material adverse effect on the Company's financial position or results of operations.
Note 18 - Subsequent Events
On February 4, 2025, the Company's Board of Directors declared a quarterly cash dividend of $0.1275 per share to be paid on March 18, 2025 to shareholders of record as of February 26, 2025. Amcor has received a waiver from the Australian Securities Exchange ("ASX") settlement operating rules, which will allow Amcor to defer processing conversions between ordinary share and CHESS Depositary Instrument ("CDI") registers from February 25, 2025 to February 26, 2025, inclusive.
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Management’s Discussion and Analysis ("MD&A") should be read in conjunction with our Form 10-K for fiscal year 2024 filed with the U.S. Securities and Exchange Commission (the "SEC") on August 16, 2024, together with the unaudited condensed consolidated financial statements and accompanying notes included in Part 1, Item 1 of this Form 10-Q. Throughout the MD&A, amounts and percentages may not recalculate due to rounding.
Summary of Financial Results
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended December 31, | | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 | | 2024 | | 2023 |
Net sales | | $ | 3,241 | | | 100.0 | % | | $ | 3,251 | | | 100.0 | % | | $ | 6,594 | | | 100.0 | % | | $ | 6,694 | | | 100.0 | % |
Cost of sales | | (2,615) | | | (80.7 | %) | | (2,630) | | | (80.9 | %) | | (5,309) | | | (80.5 | %) | | (5,428) | | | (81.1 | %) |
| | | | | | | | | | | | | | | | |
Gross profit | | 626 | | | 19.3 | % | | 621 | | | 19.1 | % | | 1,285 | | | 19.5 | % | | 1,266 | | | 18.9 | % |
| | | | | | | | | | | | | | | | |
Operating expenses: | | | | | | | | | | | | | | | | |
Selling, general, and administrative expenses | | (295) | | | (9.1 | %) | | (299) | | | (9.2 | %) | | (610) | | | (9.3 | %) | | (601) | | | (9.0 | %) |
Research and development expenses | | (27) | | | (0.8 | %) | | (28) | | | (0.9 | %) | | (55) | | | (0.8 | %) | | (55) | | | (0.8 | %) |
Restructuring and other activities, net | | (33) | | | (1.0 | %) | | (24) | | | (0.7 | %) | | (39) | | | (0.6 | %) | | (52) | | | (0.8 | %) |
Other income/(expenses), net | | 26 | | | 0.8 | % | | (28) | | | (0.9 | %) | | 28 | | | 0.4 | % | | (46) | | | (0.7 | %) |
| | | | | | | | | | | | | | | | |
Operating income | | 297 | | | 9.2 | % | | 242 | | | 7.4 | % | | 609 | | | 9.2 | % | | 512 | | | 7.6 | % |
| | | | | | | | | | | | | | | | |
Interest income | | 9 | | | 0.3 | % | | 11 | | | 0.3 | % | | 20 | | | 0.3 | % | | 21 | | | 0.3 | % |
Interest expense | | (81) | | | (2.5 | %) | | (89) | | | (2.7 | %) | | (167) | | | (2.5 | %) | | (174) | | | (2.6 | %) |
Other non-operating income/(expenses), net | | (1) | | | — | % | | 1 | | | — | % | | (2) | | | — | % | | — | | | — | % |
| | | | | | | | | | | | | | | | |
Income before income taxes and equity in income/(loss) of affiliated companies | | 224 | | | 6.9 | % | | 165 | | | 5.1 | % | | 460 | | | 7.0 | % | | 359 | | | 5.4 | % |
| | | | | | | | | | | | | | | | |
Income tax expense | | (58) | | | (1.8 | %) | | (28) | | | (0.9 | %) | | (101) | | | (1.5 | %) | | (67) | | | (1.0 | %) |
Equity in income/(loss) of affiliated companies, net of tax | | 1 | | | — | % | | (1) | | | — | % | | 1 | | | — | % | | (2) | | | — | % |
| | | | | | | | | | | | | | | | |
Net income | | $ | 167 | | | 5.2 | % | | $ | 136 | | | 4.2 | % | | $ | 360 | | | 5.5 | % | | $ | 290 | | | 4.3 | % |
| | | | | | | | | | | | | | | | |
Net income attributable to non-controlling interests | | (4) | | | (0.1 | %) | | (2) | | | (0.1 | %) | | (6) | | | (0.1 | %) | | (4) | | | (0.1 | %) |
| | | | | | | | | | | | | | | | |
Net income attributable to Amcor plc | | $ | 163 | | | 5.0 | % | | $ | 134 | | | 4.1 | % | | $ | 354 | | | 5.4 | % | | $ | 286 | | | 4.3 | % |
Overview
Amcor is a global leader in developing and producing responsible packaging solutions across a variety of materials for food, beverage, pharmaceutical, medical, home and personal-care, and other products. We work with leading companies around the world to protect products, differentiate brands, and improve supply chains. We offer a range of innovative, differentiating flexible and rigid packaging, specialty cartons, closures, and services. We are focused on making packaging that is increasingly recyclable, reusable, lighter weight, and made using an increasing amount of recycled content. In fiscal year 2024, 41,000 Amcor people generated $13.6 billion in annual sales from operations that span 212 locations in 40 countries.
Significant Developments Affecting the Periods Presented
Merger Agreement
On November 19, 2024, the Company, Aurora Spirit, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub”), and Berry Global Group, Inc., a Delaware corporation (“Berry”), entered into an Agreement and Plan of Merger (the “Merger Agreement”). The Merger Agreement provides for, among other things and subject to the satisfaction or waiver of specified conditions set forth therein, the merger of Merger Sub with and into Berry (the “Merger”), with Berry surviving the Merger as a wholly-owned subsidiary of Amcor. The board of directors of Amcor (the “Amcor Board”) and the board of directors of Berry (the “Berry Board”) have unanimously approved the Merger Agreement and the transactions contemplated thereby.
Subject to the terms and conditions set forth in the Merger Agreement, at the effective time of the Merger (the “Effective Time”), each share of Berry common stock issued and outstanding (excluding shares held by Berry as treasury stock immediately prior to the Effective Time) will be converted into the right to receive 7.25 fully paid and nonassessable Amcor ordinary shares (and, if applicable, cash in lieu of fractional shares), less any applicable withholding taxes.
Completion of the Merger is subject to the satisfaction or waiver of certain closing conditions, including, among other things: (1) the adoption of the Merger Agreement by the shareholders of Berry, (2) the approval of the issuance of Amcor ordinary shares in the Merger by the Company's shareholders, and (3) receipt of applicable regulatory approvals. On January 23, 2025, our amended proxy statement/prospectus on Form S-4 was declared effective by the SEC and Amcor and Berry shareholder meetings have been scheduled for February 25, 2025. The Company expects the transaction to close in the middle of calendar year 2025.
Economic and Market Conditions
Throughout the first half of fiscal year 2025, we continue to be impacted by softer consumer demand and customer order volatility in certain markets, and higher costs in certain areas, such as labor costs. Despite these hurdles, we have benefited from overall volume growth through the first half of fiscal year 2025. The underlying causes for the market volatility being experienced can be attributed to a variety of factors, such as geopolitical tension and conflicts, inflation in many economies impacting consumption and consumer demand, and customer destocking following a period of supply chain constraints. In this context, we have remained focused on taking price and cost actions to offset inflation and aligning our cost base with market dynamics and expect to continue to do so in fiscal year 2025. However, there is no assurance that we will meet our performance expectations or that ongoing geopolitical tensions and other factors will not negatively impact our financial results.
Russia-Ukraine Conflict / 2023 Restructuring Plan
On February 7, 2023, we announced that we expect to invest $110 million to $130 million of the sale proceeds from our Russian business sold in December 2022 for net cash proceeds of $365 million in various cost savings initiatives to partly offset divested earnings from the Russian business (the "2023 Restructuring Plan" or the "Plan").
As of December 31, 2024, we have initiated restructuring and related projects with an expected net cost of approximately $220 million, of which approximately $130 million is expected to result in net cash expenditures. From the initiation of the Plan until December 31, 2024, we have incurred $99 million in employee-related expenses, $33 million in fixed asset related expenses, $52 million in other restructuring, and $24 million in restructuring related expenses. The Plan has resulted in $96 million of cumulative net cash outflows to date. The Plan has been largely completed as of December 31, 2024. Management expects to realize an annualized pre-tax benefit of approximately $50 million from structural cost reduction actions taken as a result of all Russia related restructuring by the end of fiscal year 2025.
Highly Inflationary Accounting
We have subsidiaries in Argentina that historically had a functional currency of the Argentine Peso. As of June 30, 2018, the Argentine economy was designated as highly inflationary for accounting purposes. Accordingly, beginning July 1, 2018, we began reporting the financial results of our Argentine subsidiaries with a functional currency of the Argentine Peso at the functional currency of the parent, which is the U.S. dollar. Following the governmental election in the second quarter of fiscal year 2024, Argentina devalued the Argentine Peso by approximately 55% against the U.S. dollar. In the third quarter of fiscal year 2024, the Argentine Peso stabilized against the U.S. dollar and the Argentine peso has since been relatively stable against the U.S. dollar. The impact of highly inflationary accounting in the three months ended December 31, 2024 and 2023 resulted in a negative impact on monetary assets of $3 million and $34 million, respectively, and $5 million and $51 million in the six months ended December 31, 2024 and 2023, respectively, in foreign currency transaction losses that were reflected in the unaudited condensed consolidated statements of income. Our operations in Argentina represented approximately 2% of our consolidated net sales and annual adjusted earnings before interest and tax in the last two fiscal years.
Results of Operations - Three Months Ended December 31, 2024
Consolidated Results of Operations | | | | | | | | | | | | | | |
| | Three Months Ended December 31, |
($ in millions, except per share data) | | 2024 | | 2023 |
Net sales | | $ | 3,241 | | | $ | 3,251 | |
Operating income | | 297 | | | 242 | |
Operating income as a percentage of net sales | | 9.2 | % | | 7.4 | % |
| | | | |
Net income attributable to Amcor plc | | $ | 163 | | | $ | 134 | |
Diluted Earnings Per Share | | $ | 0.113 | | | $ | 0.092 | |
Net sales decreased by $10 million for the three months ended December 31, 2024, compared to the three months ended December 31, 2023. Excluding negative currency impacts of $39 million, the positive impacts from the pass-through of higher raw material costs of approximately $20 million, and the negative impact from disposed operations of $2 million, the remaining variation in net sales for the three months ended December 31, 2024 was an increase of approximately $15 million, reflecting higher sales volumes of approximately 2%, offset by an unfavorable price/mix impact of approximately 2%.
Net income attributable to Amcor plc increased by $29 million, or 22%, for the three months ended December 31, 2024, compared to the three months ended December 31, 2023, mainly due to an increase in gross profit of $5 million, lower selling, general, and administrative expenses of $4 million, higher other income, net, of $54 million, and lower interest expense, net of $6 million, partially offset by higher restructuring and other activities, net, of $9 million and higher income tax expenses of $30 million.
Diluted earnings per share ("Diluted EPS") increased by $0.021, or 23%, for the three months ended December 31, 2024, compared to the three months ended December 31, 2023, with the net income available to ordinary shareholders of Amcor plc increasing by 23% due to the above items and the diluted weighted average number of shares remaining in line with the prior year.
Segment Results of Operations
Flexibles Segment
| | | | | | | | | | | | | | |
| | Three Months Ended December 31, |
($ in millions) | | 2024 | | 2023 |
Net sales | | $ | 2,511 | | | $ | 2,481 | |
Adjusted EBIT | | 322 | | | 312 | |
Adjusted EBIT as a percentage of net sales | | 12.8 | % | | 12.6 | % |
Net sales increased by $30 million, or 1%, for the three months ended December 31, 2024, compared to the three months ended December 31, 2023. Excluding negative currency impacts of $22 million, the positive impacts from pass-through of higher raw material costs of $32 million, and the negative impacts from disposed operations of $2 million, the remaining variation in net sales for the three months ended December 31, 2024 was an increase of $23 million, or 1%, reflecting favorable volumes of approximately 3%, partially offset by unfavorable price/mix impacts of approximately 2%.
Adjusted earnings before interest and tax ("Adjusted EBIT") increased by $10 million or 3% for the three months ended December 31, 2024, compared to the three months ended December 31, 2023. Excluding negative currency impacts of $4 million, the remaining increase in Adjusted EBIT for the three months ended December 31, 2024, was $14 million, or 4%, driven by favorable volumes and operating costs performance, partially offset by unfavorable price/mix impacts.
Rigid Packaging Segment
| | | | | | | | | | | | | | |
| | Three Months Ended December 31, |
($ in millions) | | 2024 | | 2023 |
Net sales | | $ | 730 | | | $ | 770 | |
Adjusted EBIT | | 53 | | | 51 | |
Adjusted EBIT as a percentage of net sales | | 7.3 | % | | 6.6 | % |
Net sales decreased by $40 million, or 5%, for the three months ended December 31, 2024, compared to the three months ended December 31, 2023. Excluding negative currency impacts of $16 million and the negative impact from the pass-through of lower raw material costs of approximately $15 million, the remaining variation in net sales for the three months ended December 31, 2024 was a decrease of approximately $10 million, or 1%, reflecting unfavorable price/mix impacts of approximately 2%, partially offset by higher sales volumes of approximately 1%.
Adjusted EBIT increased by $2 million, or 5%, for the three months ended December 31, 2024, compared to the three months ended December 31, 2023. Excluding negative currency impacts of $3 million, the remaining variation in Adjusted EBIT for the three months ended December 31, 2024, was an increase of $5 million, or 10%. This growth reflects favorable operating cost performance and sales volume, partially offset by unfavorable price/mix impacts.
Consolidated Gross Profit | | | | | | | | | | | | | | |
| | Three Months Ended December 31, |
($ in millions) | | 2024 | | 2023 |
Gross profit | | $ | 626 | | | $ | 621 | |
Gross profit as a percentage of net sales | | 19.3 | % | | 19.1 | % |
Gross profit increased by $5 million, or 1%, for the three months ended December 31, 2024, compared to the three months ended December 31, 2023. The increase was primarily driven by the impact of cost savings initiatives and sales volumes increase, which also drove an increase in gross profit as a percentage of sales to 19.3% for the three months ended December 31, 2024.
Consolidated Restructuring And Other Activities, Net | | | | | | | | | | | | | | |
| | Three Months Ended December 31, |
($ in millions) | | 2024 | | 2023 |
Restructuring and other activities, net | | $ | (33) | | | $ | (24) | |
Restructuring and other activities, net as a percentage of net sales | | (1.0 | %) | | (0.7 | %) |
Restructuring and other activities, net increased by $9 million for the three months ended December 31, 2024, compared to the three months ended December 31, 2023. The change was primarily a result of transaction costs incurred in connection with the pending merger with Berry Global Group, Inc.
Consolidated Other Income/(Expenses), Net | | | | | | | | | | | | | | |
| | Three Months Ended December 31, |
($ in millions) | | 2024 | | 2023 |
Other income/(expenses), net | | $ | 26 | | | $ | (28) | |
Other income/(expenses), net as a percentage of net sales | | 0.8 | % | | (0.9) | % |
Other income/(expenses), net changed by $54 million for the three months ended December 31, 2024, compared to the three months ended December 31, 2023. The change was primarily driven by the lower negative impacts of highly inflationary accounting for subsidiaries in Argentina and the gain on the sale of the 50% equity interest in the Bericap North America closures business ("Bericap").
Consolidated Income Tax Expense
| | | | | | | | | | | | | | |
| | Three Months Ended December 31, |
($ in millions) | | 2024 | | 2023 |
Income tax expense | | $ | (58) | | | $ | (28) | |
Effective income tax rate | | 25.9 | % | | 17.0 | % |
The effective tax rate for the three months ended December 31, 2024, increased by 8.9 percentage points compared to the three months ended December 31, 2023, primarily due to the tax impact of the divestiture of Bericap in the current period, and differences in the magnitudes of non-deductible expenses and discrete events between the periods.
Results of Operations - Six Months Ended December 31, 2024
Consolidated Results of Operations | | | | | | | | | | | | | | |
| | Six Months Ended December 31, |
($ in millions, except per share data) | | 2024 | | 2023 |
Net sales | | $ | 6,594 | | | $ | 6,694 | |
Operating income | | $ | 609 | | | $ | 512 | |
Operating income as a percentage of net sales | | 9.2 | % | | 7.6 | % |
| | | | |
Net income attributable to Amcor plc | | $ | 354 | | | $ | 286 | |
Diluted Earnings Per Share | | $ | 0.244 | | | $ | 0.198 | |
Net sales decreased by $100 million, or 1%, for the six months ended December 31, 2024, compared to the six months ended December 31, 2023. Excluding the negative currency impacts of $55 million, the negative impacts from the pass-through of lower raw material costs of approximately $2 million, and the negative impacts from disposed operations of $2 million, the remaining decrease in net sales for the six months ended December 31, 2024 was $41 million, or 1%, reflecting an unfavorable price/mix impact of approximately 3%, partially offset by higher sales volumes of approximately 2%.
Net income attributable to Amcor plc increased by $68 million, or 24%, for the six months ended December 31, 2024, compared to the six months ended December 31, 2023, mainly due to an increase in gross profit of $19 million, lower restructuring and other activities, net, of $13 million, higher other income, net, of $74 million, and lower interest expense, net of $6 million, partially offset by higher selling, general, and administrative expenses of $9 million and higher income tax expenses of $34 million.
Diluted earnings per share increased by $0.046, or 23%, for the six months ended December 31, 2024, compared to the six months ended December 31, 2023, with the net income available to ordinary shareholders of Amcor plc increasing by 24% due to the above items and the diluted weighted average number of shares remaining in line with the prior year.
Segment Results of Operations
Flexibles Segment
| | | | | | | | | | | | | | |
| | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 |
Net sales | | $ | 5,062 | | | $ | 5,049 | |
Adjusted EBIT | | $ | 651 | | | $ | 634 | |
Adjusted EBIT as a percentage of net sales | | 12.9 | % | | 12.6 | % |
Net sales increased by $13 million for the six months ended December 31, 2024, compared to the six months ended December 31, 2023. Excluding the negative currency impacts of $27 million, the positive impacts from the pass-through of higher raw material costs of $36 million, and the negative impacts from disposed operations of $2 million, the remaining variation in net sales for the six months ended December 31, 2024 was an increase of $7 million, mainly reflecting favorable sales volumes of approximately 3%, offset by an unfavorable price/mix impact of approximately 3%.
Adjusted EBIT increased by $17 million, or 3%, for the six months ended December 31, 2024, compared to the six months ended December 31, 2023. Excluding negative currency impacts of $6 million, the remaining increase in Adjusted EBIT for the six months ended December 31, 2024, was $23 million, or 4%, reflecting the positive effect from favorable volumes and favorable operating cost performance, partially offset by negative price/mix.
Rigid Packaging Segment
| | | | | | | | | | | | | | |
| | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 |
Net sales | | $ | 1,532 | | | $ | 1,645 | |
Adjusted EBIT | | $ | 115 | | | $ | 113 | |
Adjusted EBIT as a percentage of net sales | | 7.5 | % | | 6.9 | % |
Net sales decreased by $113 million, or 7%, for the six months ended December 31, 2024, compared to the six months ended December 31, 2023. Excluding the negative currency impacts of approximately $25 million and the negative impacts from the pass-through of lower raw material costs of approximately $40 million, the remaining variation in net sales for the six months ended December 31, 2024 was a decrease of approximately $50 million, or 3%. This reflects an unfavorable price/mix impact of approximately 1% and unfavorable sales volumes of approximately 2%.
Adjusted EBIT increased by $2 million, or 2%, for the six months ended December 31, 2024, compared to the six months ended December 31, 2023. Excluding the negative currency impacts of $5 million, the remaining variation in Adjusted EBIT for the six months ended December 31, 2024, was an increase of $7 million, or 6%, reflecting favorable operating cost performance, partly offset by an unfavorable price/mix and lower volumes.
Consolidated Gross Profit | | | | | | | | | | | | | | |
| | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 |
Gross profit | | $ | 1,285 | | | $ | 1,266 | |
Gross profit as a percentage of net sales | | 19.5 | % | | 18.9 | % |
Gross profit increased by $19 million, or 2%, for the six months ended December 31, 2024, compared to the six months ended December 31, 2023. The increase was primarily driven by sales volumes increase and improved operating cost performance, which also drove an increase in gross profit as a percentage of sales increased to 19.5% for the six months ended December 31, 2024.
Consolidated Restructuring and Other Activities, Net | | | | | | | | | | | | | | |
| | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 |
Restructuring and other activities, net | | $ | (39) | | | $ | (52) | |
Restructuring and other activities, net, as a percentage of net sales | | (0.6 | %) | | (0.8 | %) |
Restructuring and other activities, net, changed by $13 million for the six months ended December 31, 2024, compared to the six months ended December 31, 2023. The change was a result of a decrease in restructuring and related expenses, net, of $23 million, partially offset by transaction costs incurred in connection with the pending merger with Berry Global Group, Inc.
Consolidated Other Income/(Expenses), Net
| | | | | | | | | | | | | | |
| | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 |
Other income/(expenses), net | | $ | 28 | | | $ | (46) | |
Other income/(expenses), net as a percentage of net sales | | 0.4 | % | | (0.7 | %) |
Other income/(expenses), net changed by $74 million, for the six months ended December 31, 2024, compared to the six months ended December 31, 2023, primarily driven by the lower negative impacts of highly inflationary accounting for subsidiaries in Argentina and the gain on the Bericap sale.
Consolidated Income Tax Expense | | | | | | | | | | | | | | |
| | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 |
Income tax expense | | $ | (101) | | | $ | (67) | |
Effective income tax rate | | 22.0 | % | | 18.7 | % |
The effective tax rate for the six months ended December 31, 2024, increased by 3.3 percentage points compared to the six months ended December 31, 2023, primarily due to the tax impact of the divestiture of Bericap in the current period, and differences in the magnitude of non-deductible expenses and discrete events between the periods.
Presentation of Non-GAAP Information
This Quarterly Report on Form 10-Q refers to non-GAAP financial measures: adjusted earnings before interest and taxes ("Adjusted EBIT"), earnings before interest and tax ("EBIT"), adjusted net income, and net debt. Such measures have not been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). These non-GAAP financial measures adjust for factors that are unusual or unpredictable. These measures exclude the impact of certain amounts related to the effect of changes in currency exchange rates, acquisitions, and restructuring, including employee-related costs, equipment relocation costs, accelerated depreciation, and the write-down of equipment. These measures also exclude gains or losses on sales of significant property and divestitures, significant property and other impairments, net of insurance recovery, certain regulatory and litigation matters, significant pension settlements, impairments in goodwill and equity method investments, and certain acquisition-related expenses, including transaction and integration expenses, due diligence expenses, professional and legal fees, purchase accounting adjustments for inventory, order backlog, intangible amortization, changes in the fair value of contingent acquisition payments and economic hedging instruments on commercial paper, CEO transition costs, and impacts related to the Russia-Ukraine conflict. Note that while amortization of acquired intangible assets is excluded from non-GAAP adjusted financial measures, the revenue of the acquired entities and all other expenses unless otherwise stated, are reflected in Adjusted EBIT and adjusted net income and the acquired assets contribute to revenue generation.
This adjusted information should not be construed as an alternative to results determined in accordance with U.S. GAAP. We use the non-GAAP measures to evaluate operating performance and believe that these non-GAAP measures are useful to enable investors and other external parties to perform comparisons of our current and historical performance.
A reconciliation of reported net income attributable to Amcor plc to Adjusted EBIT, and adjusted net income for the three and six months ended December 31, 2024, and 2023 is as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended December 31, | | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 | | 2024 | | 2023 |
Net income attributable to Amcor plc, as reported | | $ | 163 | | | $ | 134 | | | $ | 354 | | | $ | 286 | |
Add: Net income attributable to non-controlling interests | | 4 | | | 2 | | | 6 | | | 4 | |
| | | | | | | | |
Net income | | 167 | | | 136 | | | 360 | | | 290 | |
Add: Income tax expense | | 58 | | | 28 | | | 101 | | | 67 | |
Add: Interest expense | | 81 | | | 89 | | | 167 | | | 174 | |
Less: Interest income | | (9) | | | (11) | | | (20) | | | (21) | |
EBIT | | 297 | | | 242 | | | 608 | | | 510 | |
| | | | | | | | |
Add: Amortization of acquired intangible assets from business combinations (1) | | 40 | | | 43 | | | 79 | | | 83 | |
Add: Impact of hyperinflation (2) | | 3 | | | 34 | | | 5 | | | 51 | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Add: Restructuring and related expenses, net (3) | | 23 | | | 24 | | | 29 | | | 52 | |
| | | | | | | | |
Add: Other (4) | | — | | | 9 | | | 7 | | | 13 | |
Adjusted EBIT | | $ | 363 | | | $ | 352 | | | $ | 728 | | | $ | 709 | |
Less: Income tax expense | | (58) | | | (28) | | | (101) | | | (67) | |
Add/(Less): Adjustments to income tax expense (5) | | 4 | | | (17) | | | (7) | | | (32) | |
| | | | | | | | |
Less: Interest expense | | (81) | | | (89) | | | (167) | | | (174) | |
Add: Interest income | | 9 | | | 11 | | | 20 | | | 21 | |
Less: Net income attributable to non-controlling interests | | (4) | | | (2) | | | (6) | | | (4) | |
Adjusted net income | | $ | 233 | | | $ | 227 | | | $ | 467 | | | $ | 453 | |
(1)Amortization of acquired intangible assets from business combinations includes amortization expenses related to all acquired intangible assets from past acquisitions.
(2)Impact of hyperinflation includes the adverse impact of highly inflationary accounting for subsidiaries in Argentina where the functional currency was the Argentine Peso.
(3)Restructuring and related expenses, net, primarily includes costs incurred in connection with the 2023 Restructuring Plan. Refer to Note 6 - "Restructuring" for further information.
(4)Other includes, for the three and six months ended December 31, 2024, various expense and income items primarily relating to a pre-tax gain on the disposal of Bericap of $15 million, offset by transaction costs related to the announced Merger of $10 million, and a loss on disposal of a non-core business. Refer to Note 3 - "Pending Merger with Berry Global Group, Inc." and Note 4 -
"Acquisitions and Disposals" for further information. For the three and six months ended December 31, 2023, Other includes various expense and income items relating to acquisitions, retroactive foil duties, certain litigation reserve settlements, and fair value movements on economic hedges.
(5)Net tax impact on items (1) through (4) above.
Reconciliation of Net Debt
A reconciliation of total debt to net debt as of December 31, 2024, and June 30, 2024 is as follows:
| | | | | | | | | | | | | | |
($ in millions) | | December 31, 2024 | | June 30, 2024 |
Current portion of long-term debt | | $ | 13 | | | $ | 12 | |
Short-term debt | | 91 | | | 84 | |
Long-term debt, less current portion | | 6,837 | | | 6,603 | |
Total debt | | 6,941 | | | 6,699 | |
Less cash and cash equivalents | | (445) | | | (588) | |
Net debt | | $ | 6,496 | | | $ | 6,111 | |
Supplemental Guarantor Information
Amcor plc, along with certain wholly owned subsidiary guarantors, guarantee the following senior notes issued by the wholly owned subsidiaries, Amcor Flexibles North America, Inc., Amcor UK Finance plc., Amcor Finance (USA), Inc., and Amcor Group Finance plc.
• $500 million, 4.000% Guaranteed Senior Notes due 2025 of Amcor Flexibles North America, Inc.
• $300 million, 3.100% Guaranteed Senior Notes due 2026 of Amcor Flexibles North America, Inc.
• $600 million, 3.625% Guaranteed Senior Notes due 2026 of Amcor Flexibles North America, Inc.
• $500 million, 4.500% Guaranteed Senior Notes due 2028 of Amcor Flexibles North America, Inc.
• $500 million, 2.630% Guaranteed Senior Notes due 2030 of Amcor Flexibles North America, Inc.
• $800 million, 2.690% Guaranteed Senior Notes due 2031 of Amcor Flexibles North America, Inc.
• €500 million, 1.125% Guaranteed Senior Notes due 2027 of Amcor UK Finance plc
• €500 million, 3.950% Guaranteed Senior Notes due 2032 of Amcor UK Finance plc
• $500 million, 5.625% Guaranteed Senior Notes due 2033 of Amcor Finance (USA), Inc.
• $500 million, 5.450% Guaranteed Senior Notes due 2029 of Amcor Group Finance plc
The six notes issued by Amcor Flexibles North America, Inc. are guaranteed by its parent entity, Amcor plc, and the subsidiary guarantors Amcor Pty Ltd, Amcor Finance (USA), Inc., Amcor Group Finance plc, and Amcor UK Finance plc. The two notes issued by Amcor UK Finance plc are guaranteed by its parent entity, Amcor plc, and the subsidiary guarantors Amcor Pty Ltd, Amcor Flexibles North America, Inc., Amcor Finance (USA), Inc., and Amcor Group Finance plc. The note issued by Amcor Finance (USA), Inc. is guaranteed by its ultimate parent entity, Amcor plc, and the subsidiary guarantors Amcor Pty Ltd, Amcor Flexibles North America, Inc., Amcor Group Finance plc, and Amcor UK Finance plc. The note issued by Amcor Group Finance plc is guaranteed by its ultimate parent entity, Amcor plc, and the subsidiary guarantors Amcor Pty Ltd, Amcor Finance (USA), Inc., Amcor Flexibles North America, Inc., and Amcor UK Finance plc.
All guarantors fully, unconditionally, and irrevocably guarantee, on a joint and several basis, to each holder of the notes, the due and punctual payment of the principal of, and any premium and interest on, such note and all other amounts payable, when and as the same shall become due and payable, whether at stated maturity, by declaration of acceleration, call for redemption or otherwise, in accordance with the terms of the notes and related indenture. The obligations of the applicable guarantors under their guarantees will be limited as necessary to recognize certain defenses generally available to guarantors (including those that relate to fraudulent conveyance or transfer, voidable preference, financial assistance, corporate purpose, or similar laws) under applicable law. The guarantees will be unsecured and unsubordinated obligations of the guarantors and will rank equally with all existing and future unsecured and unsubordinated debt of each guarantor. None of our other subsidiaries guarantee such notes. The issuers and guarantors conduct large parts of their operations through other subsidiaries of Amcor plc.
Amcor Flexibles North America, Inc. is incorporated in Missouri in the United States, Amcor UK Finance plc and Amcor Group Finance plc are incorporated in England and Wales, United Kingdom, Amcor Finance (USA), Inc. is incorporated in Delaware in the United States, and the guarantors are incorporated under the laws of Jersey, Australia, the United States, and England and Wales and, therefore, insolvency proceedings with respect to the issuers and guarantors could proceed under, and be governed by, among others, Jersey, Australian, United States, or English insolvency law, as the case may be, if either issuer or any guarantor defaults on its obligations under the applicable Notes or Guarantees, respectively.
Set forth below is the summarized financial information of the combined Obligor Group made up of Amcor plc (as parent guarantor), Amcor Flexibles North America, Inc., Amcor UK Finance plc, Amcor Group Finance plc, and Amcor Finance (USA), Inc. (as subsidiary issuers of the notes and guarantors of each other’s notes), and Amcor Pty Ltd (as the remaining subsidiary guarantor).
Basis of Preparation
The following summarized financial information is presented for the parent, issuer, and guarantor subsidiaries ("Obligor Group") on a combined basis after elimination of intercompany transactions between entities in the combined group and amounts related to investments in any subsidiary that is a non-guarantor.
This information is not intended to present the financial position or results of operations of the combined group of companies in accordance with U.S. GAAP.
Statement of Income for Obligor Group | | | | | | | | |
($ in millions) | | Six Months Ended December 31, 2024 |
Net sales - external | | $ | 480 | |
Net sales - to subsidiaries outside the Obligor Group | | 5 | |
Total net sales | | 485 | |
| | |
Gross profit | | 114 | |
| | |
| | |
| | |
| | |
| | |
Net income | | $ | 179 | |
| | |
Net income attributable to non-controlling interests | | — | |
| | |
Net income attributable to Obligor Group | | $ | 179 | |
Balance Sheets for Obligor Group | | | | | | | | | | | | | | |
($ in millions) | | December 31, 2024 | | June 30, 2024 |
Assets | | | | |
Current assets - external | | $ | 1,448 | | | $ | 1,160 | |
Current assets - due from subsidiaries outside the Obligor Group | | 230 | | | 165 | |
Total current assets | | 1,678 | | | 1,325 | |
Non-current assets - external | | 1,421 | | | 1,447 | |
Non-current assets - due from subsidiaries outside the Obligor Group | | 12,405 | | | 12,538 | |
Total non-current assets | | 13,826 | | | 13,985 | |
Total assets | | $ | 15,504 | | | $ | 15,310 | |
Liabilities | | | | |
Current liabilities - external | | $ | 2,779 | | | $ | 2,341 | |
Current liabilities - due to subsidiaries outside the Obligor Group | | 36 | | | 34 | |
Total current liabilities | | 2,815 | | | 2,375 | |
Non-current liabilities - external | | 7,018 | | | 6,815 | |
Non-current liabilities - due to subsidiaries outside the Obligor Group | | 10,594 | | | 10,822 | |
Total non-current liabilities | | 17,612 | | | 17,637 | |
Total liabilities | | $ | 20,427 | | | $ | 20,012 | |
New Accounting Pronouncements
Refer to Note 2, "New Accounting Guidance," in "Item 1. Financial Statements - Notes to Condensed Consolidated Financial Statements".
Critical Accounting Estimates and Judgments
Our discussion and analysis of our financial condition and results of operations is based on our unaudited condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Our estimates and judgments are based on historical experience and on various other factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. These critical accounting estimates are discussed in detail in “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Estimates and Judgments” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. There have been no material changes in critical accounting estimates and judgments as of December 31, 2024, from those described in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
Liquidity and Capital Resources
We finance our business primarily through cash flows provided by operating activities, borrowings from banks, and proceeds from issuances of debt and equity. We periodically review our capital structure and liquidity position in light of market conditions, expected future cash flows, potential funding requirements for debt refinancing, capital expenditures and acquisitions, the cost of capital, sensitivity analyses reflecting downside scenarios, the impact on our financial metrics and credit ratings, and our ease of access to funding sources.
We believe that our cash flows provided by operating activities, together with borrowings available under our credit facilities and access to the commercial paper market, backstopped by our bank debt facilities, will continue to provide sufficient liquidity to fund our operations, capital expenditures, and other commitments, including dividends and purchases of our ordinary shares and CHESS Depositary Instruments under authorized share repurchase programs, into the foreseeable future.
Overview
| | | | | | | | | | | | | | |
| | Six Months Ended December 31, |
($ in millions) | | 2024 | | 2023 |
Net cash provided by operating activities | | $ | 159 | | | $ | 228 | |
Net cash used in investing activities | | (134) | | | (256) | |
Net cash used in financing activities | | (143) | | | (191) | |
Cash Flow Overview
Net Cash Provided by Operating Activities
Net cash provided by operating activities decreased by $69 million for the six months ended December 31, 2024, compared to the six months ended December 31, 2023. The change is primarily driven by higher working capital outflows in the current period and lower net income after adjusting for non-cash items in the current period as compared to the prior period.
Net Cash Used in Investing Activities
Net cash used in investing activities decreased by $122 million for the six months ended December 31, 2024, compared to the six months ended December 31, 2023. The change is primarily driven by the proceeds received from the sale of Bericap in the current period.
Net Cash Used in Financing Activities
Net cash used by financing activities decreased by $48 million for the six months ended December 31, 2024, compared to the six months ended December 31, 2023. The change is primarily driven by prior period share buyback activity which did not reoccur in the current period.
Net Debt
We borrow from financial institutions and debt investors in the form of bank overdrafts, bank loans, corporate bonds, unsecured notes, and commercial paper. We have a mixture of fixed and floating interest rates and use interest rate swaps to provide further flexibility in managing the interest cost of borrowings.
On August 5, 2024, we entered into an interest rate swap contract for a notional amount of $500 million, which was subsequently downsized to $400 million notional on November 4, 2024. Under the terms of the contract, we will pay a fixed rate of interest of 4.30% and receive a variable rate of interest, based on compound overnight SOFR, effective from August 12, 2024, through June 30, 2025, with monthly settlements commencing on September 1, 2024. The interest rate swap contract will economically hedge the SOFR component of our forecasted commercial paper issuances.
Short-term debt consists of bank debt with a duration of less than 12 months and bank overdrafts which are classified as current due to the short-term nature of the borrowings, except where we have the ability and intent to refinance and as such extend the debt beyond 12 months. The current portion of long-term debt consists of debt amounts repayable within a year after the balance sheet date.
Our primary bank debt facilities and notes are unsecured and subject to negative pledge arrangements limiting the amount of secured indebtedness we can incur to 10.0% of our total tangible assets, subject to some exceptions and variations by facility. In addition, the covenants of the bank debt facilities require us to maintain a leverage ratio not higher than 3.9 times. The negative pledge arrangements and the financial covenants are defined in the related debt agreements. As of December 31, 2024, we were in compliance with all applicable covenants under our bank debt facilities.
Our net debt as of December 31, 2024, and June 30, 2024 was $6.5 billion and $6.1 billion, respectively.
Debt Facilities
As of December 31, 2024, we had undrawn committed credit facilities available in the amount of $2.1 billion. Our senior facilities are available to fund working capital, growth capital expenditures, and refinancing obligations and are provided to us by two bank syndicates. On April 23, 2024, we extended the maturity of our three-year syndicated facility agreement by one year until April 2026. The three-year syndicated facility agreement will be reduced from $1.9 billion to $1.7 billion effective April 2025. Our five-year syndicated credit facility matures in April 2027 and provides a revolving credit facility of $1.9 billion. The three-year facility has one 12-month option available to us to extend the maturity date and the five-year facility has two 12-month options available to us to extend the maturity date.
As of December 31, 2024, the revolving senior bank debt facilities had an aggregate limit of $3.8 billion, of which $1.7 billion had been drawn (inclusive of amounts drawn under commercial paper programs reducing the overall balance of available senior facilities). Subject to certain conditions, we can request the total commitment level under each agreement to be increased by up to $500 million.
In connection with the contemplated Merger (refer to Note 3, "Pending Merger with Berry Global Group, Inc."), the Company entered into a commitment letter with lending institutions, dated as of November 19, 2024, to provide a 364-day senior unsecured bridge loan facility (the "Bridge Facility") in an aggregate principal amount of up to $3.0 billion to fund the repayment of certain outstanding debt of Berry upon the closing of the Merger, and the payment of fees and expenses related to the Merger. The Company paid a commitment fee of $11 million on the Bridge Facility in the three months ended December 31, 2024. The principal amount will be available in a single drawing on the closing date of the Merger. The Bridge Facility is subject to customary terms and conditions.
As of December 31, 2024, the Company had not converted the commitment into a Bridge Facility and therefore there were no outstanding borrowings on the Bridge Facility. If the Company obtains additional funding by issuing securities or obtaining other loans, the amount of the Bridge Facility will be correspondingly reduced.
Dividend Payments
We declared and paid a $0.1250 cash dividend per ordinary share during the three months ended September 30, 2024 and a $0.1275 cash dividend per ordinary share during the three months ended December 31, 2024.
Credit Rating
Our capital structure and financial practices have earned us investment grade credit ratings from two internationally recognized credit rating agencies. These investment grade credit ratings are important to our ability to issue debt at favorable rates of interest, for various terms, and from a diverse range of markets that are highly liquid, including European and U.S. debt capital markets, and from global financial institutions.
Share Repurchases
On February 7, 2023, our Board of Directors approved a $100 million buyback of ordinary shares and/or CHESS Depositary Instruments ("CDIs") in the following twelve months. On February 6, 2024, our Board of Directors extended the approval for the remaining $39 million of ordinary shares and CDIs of the $100 million buyback for twelve months. During the six months ended December 31, 2024, no shares were repurchased under this program.
We had cash outflows of $47 million and $48 million for the purchase of our own shares during the six months ended December 31, 2024, and 2023, respectively, as treasury shares to satisfy the vesting and exercises of share-based compensation awards. As of December 31, 2024, and June 30, 2024, we held treasury shares at a cost of $10 million and $11 million, respectively, representing approximately 1 million shares at both dates.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes in our market risk during the three months ended December 31, 2024. For additional information, refer to Note 9, "Fair Value Measurements," and Note 10, "Derivative Instruments," in the notes to our unaudited condensed consolidated financial statements, and to "Item 7A. - Quantitative and Qualitative Disclosures About Market Risk" of our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2024. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and financial officers, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of December 31, 2024.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the second quarter of fiscal year 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Part II - Other Information
Item 1. Legal Proceedings
The material set forth in Note 17, "Contingencies and Legal Proceedings," in "Item 1. Financial Statements - Notes to Condensed Consolidated Financial Statements" is incorporated herein by reference.
Item 1A. Risk Factors
Other than the risk factors set forth below, there have been no material changes from the risk factors contained in "Item 1A. - Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. Additional risks not currently known to us or that we currently deem to be immaterial may also materially affect our consolidated financial position, results of operations, or cash flows.
Risks Relating to the Pending Merger of Amcor and Berry
The Merger is subject to a number of conditions that may not be satisfied on a timely basis or at all and the Merger Agreement may be terminated in accordance with its terms. As a result, there is no assurance when or if the Merger will be completed.
Our obligation to complete the Merger is subject to a number of conditions that must be satisfied (or waived, to the extent permitted by law), including (i) the approval by (a) Amcor Ordinary Shares and (b) Amcor CDIs issued by Amcor through CHESS Depositary Nominees Pty Limited (collectively, "Amcor Shareholders") of a proposal to approve the issuance of Amcor Ordinary Shares to Berry Stockholders in connection with the Merger (such issuance, the “Share Issuance,” and such proposal, the “Amcor Share Issuance Proposal”); (ii) the approval by holders of Berry Common Stock (“Berry Stockholders”) of a proposal to adopt the Merger Agreement, as it may be amended from time to time (the “Berry Merger Proposal”); (iii) the expiration or earlier termination of any applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") and there not being in effect any agreement with either the Federal Trade Commission ("FTC") or Antitrust Division of the U.S. Department of Justice ("DOJ") not to consummate the Merger; (iv) the receipt of required authorizations or consents from federal, state, local or foreign governmental entity under certain antitrust or foreign investment law; (v) the absence of any law or order that has the effect of enjoining or otherwise prohibiting the consummation of the Merger; (vi) the effectiveness of the registration statement, and approval for listing on the New York Stock Exchange ("NYSE"), with respect to the issuance of Amcor; (vii) the approval for listing of Amcor Ordinary Shares to be issued to Berry Stockholders in connection with the Merger; (viii) subject to certain exceptions, the accuracy of the representations and warranties of Amcor and Berry; (ix) no change has occurred that has had, or would reasonably be expected to have, a material adverse effect with respect to Amcor and Berry; and (x) performance in all material respects by Amcor and Berry of their respective obligations under the Merger Agreement. Many of these conditions to the consummation of the Merger are beyond our control and we cannot predict when, or if, these conditions will be satisfied or waived. Accordingly, the Merger may not be completed on the expected timing or at all.
In addition, either Amcor or Berry may terminate the Merger Agreement under certain circumstances, subject to the payment of a termination fee in certain cases. The termination fee contemplated by the Merger Agreement may have the effect of discouraging alternative transaction proposals involving Amcor or Berry. Any delay in completing the Merger could cause the combined company not to realize, or to be delayed in realizing, some or all of the benefits that we expect to achieve if the Merger is successfully completed within its expected timeframe. Additionally, any delays in receipt of required regulatory approvals or satisfaction of the closing conditions will increase the length of time that we are subject to certain restrictive covenants under the Merger Agreement during the pendency of the Merger and increases the risk of disruptions to our operations and business relationships.
Regulatory approvals may not be received, may take longer than expected or may impose conditions that are not presently anticipated or cannot be met.
Under the terms of the Merger Agreement, we are obligated to use (and to cause our subsidiaries to use) reasonable best efforts to obtain the necessary regulatory approvals and consents to complete the Merger.
The governmental entities from which these approvals are required have broad discretion in administering applicable laws and regulations and may take into account various facts and circumstances in their consideration of the Merger. These governmental entities may be affected by government shutdowns, which could result in delays regarding any potential approvals or other actions, or other changes in the regulatory or legislative landscape. These governmental entities may initiate proceedings seeking to prevent the Merger. As a condition to the approval of the Merger or other transactions contemplated by
the Merger Agreement, these governmental entities also may seek to impose requirements, limitations or costs, require divestitures or place restrictions on the conduct of the combined company after consummation of the Merger and neither Amcor or Berry is required under the Merger Agreement to agree to any such divestitures, remedies or other restrictions; provided, however, in furtherance of obligations pursuant to the Merger Agreement, Amcor will and will cause its subsidiaries (including, following the consummation of the Merger, Berry and its subsidiaries) to, if necessary to resolve, avoid or eliminate impediments or objections, if any, that may be asserted with respect to the Merger under any antitrust law or foreign investment law, propose, commit to, effect or agree to, by consent decree, hold separate order, agreement or otherwise, (x) the sale, divestiture, license, holding separate or other disposition of businesses, assets, properties or product lines of Amcor, Berry or any of their respective subsidiaries that generated, in the aggregate, net sales of no more than $550 million during the 12-month period ended on June 30, 2024, or (y) any obligations or restrictions on future conduct or freedom of action of the businesses, assets, properties or product lines of Amcor, Berry or any of their respective subsidiaries (but Amcor is not required to agree to take or enter into any action (or refrain from taking any action) with respect to any such obligations or restrictions on future conduct or freedom of action of such businesses, assets, properties or product lines which would have more than a de minimis impact on the business of Amcor and Berry and their respective subsidiaries, taken as a whole). Under the terms of the Merger Agreement, we are obligated to use (and to cause our subsidiaries to use) reasonable best efforts to obtain the necessary regulatory approvals to complete the Merger.
Amcor and Berry may waive one or more of the conditions to the consummation of the Merger without resoliciting shareholder or stockholder approval, as applicable, and may terminate the Merger Agreement even if the Amcor Shareholder Approval and the Berry Stockholder Approval have been obtained.
Certain conditions of the Merger may be waived, in whole or in part, to the extent permitted by applicable law, by agreement of Amcor and Berry if the condition is a condition to both parties’ obligation to complete the Merger or by the party for which such condition is a condition of its obligation to complete the Merger. In addition, Amcor and Berry can agree to terminate the Merger Agreement even if Amcor Shareholders have already approved the Amcor Share Issuance Proposal and Berry Stockholders have already approved the Berry Merger Proposal.
Failure to complete the Merger could negatively impact our business and financial results and the market prices of Amcor Ordinary Shares and Amcor CDIs.
If the Merger is not completed for any reason, including because Amcor Shareholders fail to approve the Amcor Share Issuance Proposal or because Berry Stockholders fail to approve the Berry Merger Proposal, the ongoing businesses of Amcor and Berry may be adversely affected and, without realizing any of the expected benefits of having completed the Merger, Amcor and Berry would be subject to a number of risks, including the following:
•we may experience negative reactions from the financial markets, including negative impacts on the market prices of Amcor Ordinary Shares and Amcor CDIs;
•we may experience negative reactions from our customers, business partners, suppliers, regulators and employees;
•we will be required to pay certain transaction costs incurred in connection with the Merger, such as financial advisory, legal, accounting and printing fees, whether or not the Merger is completed;
•we may be required to pay a termination fee under certain circumstances;
•the Merger Agreement places certain restrictions on the conduct of our business prior to consummation of the Merger, which could delay or prevent us from pursuing certain business opportunities, executing business strategies, or taking certain other specified actions during the pendency of the Merger and, which could limit our ability to respond to competitive or other developments or opportunities that arise prior to the completion of the Merger;
•we will have committed substantial time and resources to matters relating to the Merger (including arranging financing and integration planning) which would otherwise have been devoted to day-to-day operations and other opportunities that may have been beneficial to us as an independent company; and
•we may be subject to litigation related to any failure to complete the Merger or related to any proceeding to specifically enforce our obligations pursuant to the Merger Agreement.
If the Merger is not completed and any of these risks materialize, they may materially and adversely affect Amcor’s business, results of operations, and financial condition, and the market prices of Amcor Ordinary Shares and Amcor CDIs.
During the pendency of the Merger, we are subject to certain restrictions on our business activities.
Under the terms of the Merger Agreement, we are subject to certain restrictions on our business activities prior to consummation of the Merger. In general, we are required to conduct our business in the ordinary course, subject to certain
exceptions. These restrictions may constrain or prevent us from pursuing business opportunities or executing on business strategies, which could limit our ability to respond to competitive or other developments that arise prior to the consummation of the Merger and could negatively affect our business, results of operations and financial condition. To the extent consummation of the Merger is delayed or the Merger Agreement is terminated, adverse effects arising from these restrictions could be exacerbated.
The Merger Agreement limits our ability to pursue alternatives to the Merger.
The Merger Agreement contains provisions that make it more difficult for us to enter into certain business combination transactions with a third party. The Merger Agreement contains certain provisions that restrict our ability to, among other things, solicit, initiate or knowingly encourage, or take any other action to knowingly facilitate any alternative transaction, participate in any discussions or negotiations, or cooperate in any way with any person, with respect to any alternative transaction, subject to certain exceptions set forth in the Merger Agreement. In addition, following receipt by us of any alternative transaction proposal that constitutes a superior proposal, we will be required to discuss and negotiate in good faith with Berry to modify the terms of the Merger Agreement before the Amcor Board may withdraw or qualify its recommendation with respect to the Amcor Share Issuance Proposal, in favor of such superior proposal. These provisions could discourage a potential third-party acquirer, strategic transaction partner or business combination partner that might have an interest in acquiring or combining with all or a significant portion of Amcor or pursuing an alternative transaction from considering or proposing such a transaction.
If the Merger Agreement is terminated and Amcor determines to seek another business combination transaction, Amcor may not be able to successfully negotiate a transaction with another party on terms comparable to, or better than, the terms of the Merger. In addition, upon termination of the Merger Agreement under certain specified circumstances, Amcor may be required to pay a termination fee of $260 million to the other party.
We may have difficulty attracting, motivating, and retaining executives and other key employees, which could adversely affect our current business and operations during the pendency of the Merger and the future business and operations of the combined company following the Merger.
The success of the Merger will depend in part on Amcor’s and Berry’s ability to retain the talents and dedication of the professionals currently employed by them. Uncertainty about the effect of the Merger on Amcor and Berry employees and future operations may have an adverse effect on Amcor’s and Berry’s ability to attract, retain and motivate key personnel. Employee retention may be particularly challenging during the pendency of the Merger, as employees may experience uncertainty about their future roles in the combined company. If we are unable to retain key employees, we could face the loss of institutional knowledge and other operational, financial and strategic disruptions, which may diminish the anticipated benefits of the Merger and may have a negative effect on our business and operations during the pendency of the Merger.
It is possible that these employees may decide not to remain with Amcor or Berry while the Merger is pending, or with the combined company following consummation of the Merger, including because of issues relating to the uncertainty and difficulty of integration, financial security or a desire not to become employees of the combined company. If key employees terminate their employment, or if an insufficient number of employees are retained to maintain effective operations, Amcor and the combined company may have to incur significant costs in identifying, hiring, training and retaining replacements for departing employees and may lose significant expertise and talent. In addition, if Amcor and Berry are unable to retain personnel, including key management, who are critical to the future operations of the companies, Amcor could face disruptions to or distractions for management and the workforce as a whole, including disruptions associated with integrating employees into the combined company, loss of existing customers and loss of key information, expertise, skill sets or know-how. Moreover, Amcor and Berry may not be able to locate suitable replacements for any key employees that leave or offer employment to potential replacements on reasonable terms. As a result, the combined company’s ability to realize the anticipated benefits of the Merger may be materially and adversely affected. No assurance can be given that the combined company will be able to attract or retain key employees of Amcor and Berry to the same extent that those companies have been able to attract or retain their employees in the past.
Whether or not the Merger is completed, the pendency of the Merger could cause disruptions in our business and business relationships, which could have an adverse effect on our business, results of operations, and financial results pending and following the Merger.
The announcement and pendency of the Merger could cause disruptions in our business, including by diverting the attention of management and other employees, including those involved in day-to-day operations of the business, toward the
consummation of the Merger. In addition, management has devoted significant management time and other resources in an effort to complete the Merger. If the Merger is not completed, we will have incurred significant costs, including the diversion of management resources, for which we will have received little or no benefit.
Parties with whom we do business may experience uncertainty associated with the Merger, including with respect to existing or future business relationships following the Merger. Our business relationships may be subject to disruption if suppliers, customers or other third-party business partners attempt to delay or defer entering into new business relationships, negotiate changes in existing business relationships or consider entering into business relationships with parties other than Amcor or Berry during the pendency of or following the Merger. These disruptions could have a material and adverse effect on our business, results of operations and financial condition, regardless of whether the Merger is completed, as well as a material and adverse effect on the combined company’s ability to realize the expected benefits of the Merger. The adverse effect of any such disruption could be exacerbated by a delay in consummation of the Merger or termination of the Merger Agreement.
We expect to incur substantial costs in connection with the Merger.
We have incurred and expect to continue to incur a substantial amount of non-recurring costs associated with negotiating and completing the Merger, combining the operations of the two companies and working to achieve synergies, including financial, legal, accounting and consulting advisory fees, employee retention, severance and benefit costs, public relations, proxy solicitation and filing fees and printing and mailing costs. Some of these costs are payable regardless of whether the Merger is completed.
The combined company will also incur restructuring and integration costs in connection with the Merger. There are processes, policies, procedures, operations, technologies and systems that must be integrated in connection with the Merger and the integration of Berry’s business into the combined company. The elimination of duplicative costs, strategic benefits and additional income, as well as any realization of other efficiencies related to the integration of the businesses, may not offset transaction and integration costs in the near term or at all. While we have assumed that certain expenses would be incurred in connection with the Merger and the other transactions contemplated by the Merger Agreement, there are many factors beyond our control that could affect the total amount or the timing of such expenses.
We may be a target of securities class action and derivative lawsuits, which could result in substantial costs and may delay or prevent the Merger from being completed.
Securities class action lawsuits and derivative lawsuits are often brought against public companies that have entered into acquisition or merger agreements. Even if the lawsuits are without merit, defending against these claims can result in substantial costs and divert management time and resources. An adverse judgment could result in monetary damages, which could have a negative impact on our liquidity and financial condition. Additionally, if a plaintiff is successful in obtaining an injunction prohibiting consummation of the Merger, that injunction may delay or prevent the transaction from being completed, which may adversely affect our business, results of operations and financial condition.
Risks Relating to the Combined Company
The combined company may be unable to successfully integrate the businesses of Amcor and Berry in the expected time frame or at all.
The success of the Merger will depend on, among other things, our ability to successfully integrate our business with the business of Berry. The combination of two independent businesses is complex, costly and time consuming, and we will be required to devote significant management time and resources to integrating the businesses and operations of the two companies. Challenges involved in this integration includes the following:
•combining the businesses of Amcor and Berry in a manner that permits the combined company to achieve the synergies, efficiencies and growth opportunities anticipated to result from the Merger;
•retaining and integrating personnel;
•harmonizing each company’s operating practices, employee development and compensation programs, internal controls and other policies, procedures and processes;
•maintaining existing relationships with each company’s customers, suppliers and other partners and leveraging relationships with such third parties for the benefit of the combined company;
•addressing possible differences in business backgrounds, corporate cultures and management philosophies;
•consolidating each company’s administrative and information technology infrastructure; and
•coordinating geographically dispersed organizations.
There can be no assurances that our business can be integrated successfully with the business of Berry. If we are not able to successfully integrate Berry’s business into the combined company within the anticipated time frame, or at all, the benefits of the Merger may not be realized fully, or at all, or may take longer to realize than expected.
If key employees terminate their employment, or if an insufficient number of employees are retained to maintain effective operations, the combined company may have to incur significant costs in identifying, hiring, training and retaining replacements for departing employees and may lose significant expertise and talent. In addition, if we are unable to retain personnel, including key management, who are critical to the future operations of the companies, we could face disruptions to or distractions for management and the workforce as a whole. It is possible that the integration process could result in our inability to maintain relationships with our and Berry’s customers, suppliers, strategic partners and other business relationships, the disruption our ongoing business, inconsistencies in standards, controls, procedures and policies, unexpected integration issues, and higher than expected integration costs.
We may not have discovered certain liabilities or other matters related to Berry, which may adversely affect the future financial performance of the combined company.
In the course of the due diligence review that we conducted prior to the execution of the Merger Agreement, we may not have discovered, or may have been unable to properly quantify, certain liabilities of Berry or other factors that may have an adverse effect on the business, results of operations, financial condition and cash flows of the combined company after the consummation of the Merger.
The combined company may be unable to realize the anticipated benefits of the Merger.
The combined company’s ability to realize the anticipated benefits of the Merger in the time frame anticipated, or at all, is subject to a number of assumptions, which may or may not prove to be accurate, and other factors, many of which are beyond our control. Difficulties in successfully integrating the two businesses and managing the expanded operations of the combined company could result in increased costs, decreased revenue and the diversion of management’s time, any of which could have a material adverse effect on the business, results of operations and financial condition of the combined company. Even if the two businesses are integrated successfully, the combined company may not fully realize the anticipated benefits of the Merger, including the anticipated cost savings, synergies and other efficiencies, that are currently expected. Moreover, some of the anticipated benefits are not expected to occur for a period of time following the consummation of the Merger and may involve unanticipated costs in order to be fully realized. If the combined company is not able to achieve these objectives and realize the anticipated benefits expected from the Merger within the anticipated timeframe or at all, its business, results of operations and financial condition could be adversely affected and the market price of Amcor Ordinary Shares could be negatively impacted.
Consummation of the Merger may trigger change in control, assignment or other provisions in certain agreements to which Berry is a party, which may have an adverse impact on the combined company’s business, results of operations and financial condition.
The consummation of the Merger may trigger change in control, assignment and other provisions in certain agreements to which Berry or any of its subsidiaries is a party. If Berry is unable to negotiate modifications, waivers or consents with respect to those provisions, the counterparties may exercise their rights and remedies under the agreements, potentially terminating the agreements or seeking monetary damages or other remedies. Even if Berry is able to negotiate modifications, waivers or consents, the counterparties may require a fee for such modifications, waivers or consents or seek to renegotiate the agreements on terms less favorable to the combined company. Any of the foregoing or similar developments may have an adverse impact on the business, results of operations and financial condition of the combined company and its ability to successfully integrate the two businesses.
Third parties may seek to modify contractual relationships with the combined company, which could have an adverse effect on the combined company’s business and operations.
As a result of the Merger, the combined company may experience impacts on relationships with third parties, including customers, suppliers and other partners, that may harm the combined company’s business, results of operations and financial condition. Certain counterparties may seek to terminate or modify contractual obligations following the Merger whether or not contractual rights are triggered as a result of the Merger. If any contractual counterparties seek to terminate or modify
contractual obligations or discontinue the relationship with the combined company, then the combined company’s business, results of operations and financial condition may be harmed.
The combined company’s significant indebtedness may limit its flexibility and increase its borrowing costs.
The combined company’s indebtedness following the consummation of the Merger may have the effect, among other things, of reducing its flexibility to respond to changing business and economic conditions and increasing borrowing costs. In addition, the amount of cash required to service the indebtedness levels will be greater than the amount of cash flows required to service the indebtedness of Amcor or Berry individually prior to the Merger. The level of indebtedness could also reduce funds available to fund integration efforts and realize expected benefits of the Merger or engage in investments in product development, capital expenditures, dividend payments, share repurchases and other activities and may create competitive disadvantages relative to other companies with lower debt levels. The combined company may be required to raise additional financing for working capital, capital expenditures, acquisitions or other general corporate purposes. The combined company’s ability to arrange additional financing or refinancing will depend on, among other factors, its financial condition and performance, as well as prevailing market conditions and other factors beyond its control. There can be no assurance that the combined company will be able to obtain additional financing or refinancing on acceptable terms or at all.
Adverse changes in Amcor’s or Berry’s credit ratings may adversely affect Amcor’s or the combined company’s respective businesses, results of operations and financial condition.
Credit ratings impact the cost and availability of future borrowings, and, as a result, cost of capital. Credit ratings reflect each rating organization’s opinion of a company’s financial strength, operating performance and ability to meet debt obligations. Each of the ratings organizations reviews Amcor’s and Berry’s ratings periodically, and there can be no assurance that Amcor’s or Berry’s current ratings will be maintained in the future. Downgrades in Amcor’s or Berry’s credit ratings could adversely affect Amcor’s or the combined company’s business, results of operations and financial condition. In addition, if the Merger is completed and Berry’s debt securities are downgraded and rated below investment grade, this may, in certain circumstances, constitute a change of control triggering event under the indentures governing such debt. Upon the occurrence of a change of control triggering event, Berry would be required to offer to repurchase certain of its outstanding notes at 101% of the principal amount thereof plus accrued and unpaid interest if any, to, but excluding, the date of repurchase. Amcor cannot provide any assurance that there will be sufficient funds available for Amcor to make any required repurchases of any of Berry’s outstanding notes upon a change of control triggering event.
The future results of the combined company may be adversely impacted if the combined company does not effectively manage its expanded operations following consummation of the Merger.
Following consummation of the Merger, the size of the combined company’s business will be significantly larger than the current size of Amcor’s business. The combined company’s ability to successfully manage this expanded business will depend, in part, upon management’s ability to implement an effective integration of the two companies and its ability to manage a combined business with significantly larger size and scope with the associated increased costs and complexity. There can be no assurances that the management of the combined company will be successful or that the combined company will realize the expected operating efficiencies, cost savings and other benefits currently anticipated from the Merger.
The market price of Amcor Ordinary Shares and Amcor CDIs following the Merger and may be affected by factors different from, or in addition to, those that historically have affected or currently affect the market prices of Amcor Ordinary Shares and Amcor CDIs.
Amcor’s business differs from that of Berry and following the consummation of the Merger, Amcor will operate an expanded business with more assets and a different mix of liabilities. Amcor’s results of operations, financial condition and the market price of Amcor Ordinary Shares may be adversely affected by factors different from those that historically have affected our results of operations, financial condition, and market price. Accordingly, the market price and performance of Amcor Ordinary Shares is likely to be different from the performance of Amcor Ordinary Shares in the absence of the Merger.
Specific factors that may have a significant effect on the market price of Amcor Ordinary Shares and Amcor CDIs include, among others, the following:
•changes in stock market analyst recommendations or earnings estimates regarding Amcor Ordinary Shares or other comparable companies;
•actual or anticipated fluctuations in Amcor’s revenue stream or future prospects;
•reaction to public announcements by Amcor following the Merger;
•strategic actions taken by Amcor or its competitors, such as acquisitions;
•failure of Amcor to achieve the perceived benefits of the Merger, including expected financial results and anticipated synergies, as rapidly as or to the extent anticipated by Amcor or financial or industry analysts;
•new laws or regulations or new interpretations of existing laws or regulations applicable to Amcor’s business and operations or the packaging industry;
•changes in tax or accounting standards, policies, guidance, interpretations or principles; and
•adverse conditions in the financial markets or general U.S. or international economic conditions, including those resulting from war, incidents of terrorism and responses to such events.
In addition, Amcor Shareholders may not wish to continue to invest in the combined company or may wish to reduce their investment in the combined company, including in order to comply with institutional investing guidelines, to increase diversification, to track any rebalancing of stock indices in which Amcor Ordinary Shares are included, to respond to the risk profile of the combined company or to realize a gain. If, following the Merger, large amounts of Amcor Ordinary Shares are sold, the market price of Amcor Ordinary Shares could decline.
Declaration, payment and amounts of dividends, if any, distributed to Amcor Shareholders following the Merger will be uncertain.
Although Amcor has paid cash dividends on Amcor Ordinary Shares and Amcor CDIs in the past, the Amcor Board may determine, following the consummation of the Merger, not to declare dividends in the future or may reduce the amount of dividends paid in the future. Any payment of future dividends will be at the discretion of the Amcor Board and will depend on Amcor’s results of operations, financial condition, cash requirements, future prospects and other considerations that the Amcor Board deems relevant, including, but not limited to:
•decisions on whether, when and in which amounts to make any future distributions will remain at all times entirely at the discretion of the Amcor Board, which could change its dividend practices at any time and for any reason;
•Amcor’s desire to maintain or improve the credit ratings on its debt;
•restrictions on making a distributions under the Jersey Companies Law; and
•the agreements governing Amcor’s indebtedness.
Amcor Shareholders should be aware that they have no contractual or other legal right to dividends that have not been declared. In addition, as a Jersey public limited company and UK resident for tax purposes, Amcor does not and will not pay franked dividends for Australian tax purposes.
Current Amcor Shareholders will have a reduced share of ownership and voting interest in the combined company following the Merger.
Amcor Shareholders as of immediately prior to the Merger are expected to collectively own approximately 63% of the outstanding capital stock of Amcor and Berry Stockholders as of immediately prior to the Merger are expected to collectively own approximately 37% of the outstanding capital stock of Amcor, each calculated based on the fully diluted market capitalizations of Amcor and Berry as of the date of signing of the Merger Agreement. As a result, current Amcor Shareholders will have less influence over the management and policies of Amcor following the consummation of the Merger than they currently have over the management and policies of Amcor. The exact ownership interests of Amcor Shareholders in the combined company immediately following the Merger will depend on the number of Amcor Ordinary Shares and the number of shares of Berry Common Stock issued and outstanding immediately prior to the Effective Time.
Risks Relating to Tax Matters
Additional tax liabilities could have a material impact on Amcor’s financial condition, results of operations, and/or liquidity.
We operate in a number of jurisdictions and will accordingly be subject to tax in several jurisdictions. The tax rules to which our entities are subject are complex and Amcor and its current and future subsidiaries will be required to make judgments (including certain judgments based on external advice) as to the interpretation and application of these rules, both as to the Merger and as to the operations of Amcor and our current and future subsidiaries. The interpretation and application of these laws could be challenged by relevant governmental authorities, which could result in administrative or judicial procedures, actions or sanctions, the ultimate outcome of which could adversely affect us after the Merger. We are currently subject to ongoing routine tax inquiries, investigations, and/or audits in various jurisdictions and the tax affairs of Amcor and our current
and future subsidiaries will in the ordinary course be reviewed by tax authorities, who may disagree with certain positions taken and assess additional taxes. We will regularly assess the likely outcomes of such tax inquiries, investigations or audits in order to determine the appropriateness of our tax provisions. However, there can be no assurance that we will accurately predict the outcomes of these inquiries, investigations or audits and the actual outcomes of these inquiries, investigations or audits could have a material impact on our financial results.
Operational Risk
Attracting and Retaining Skilled Workforce — If we are unable to attract and retain our global executive management team and our skilled workforce, we may be adversely affected.
Our continued success depends on our ability to identify, attract, develop, and retain skilled and diverse personnel in our global executive management team and our operations. We focus on our talent acquisition processes, as well as our onboarding and talent and leadership programs, to ensure that our key new hires and skilled personnel’s efficiency and effectiveness align with Amcor’s values and ways of working. In March 2024, we announced the retirement of our Chief Executive Officer Ron Delia and the appointment of Peter Konieczny as our Interim Chief Executive Officer. On September 4, 2024, after a robust internal and external search, the Board of Directors of the Company appointed Mr. Konieczny as the Chief Executive Officer of the Company, effective immediately. Any failure to successfully transition key roles could impact our ability to execute on our strategic plans, make it difficult to meet our performance objectives, and be disruptive to our business.
We are also, at times, impacted by regional labor shortages, inflationary pressures on wages, a competitive labor market, and changing demographics. While we have been successful to date in responding to regional labor shortages and maintaining plans for continuity of succession, there can be no assurance that we will be able to manage future labor shortages or recruit, develop, assimilate, motivate, and retain employees in the future who actively promote and meet the standards of our culture.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Share Repurchases
We did not repurchase shares during the three months ended December 31, 2024. The table below is presented in millions, except number of shares, which are reflected in thousands, and per share amounts, which are expressed in U.S. dollars:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Period | | Total Number of Shares Purchased | | Average Price Paid Per Share | | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Programs (1) | |
October 1 - 31, 2024 | | — | | | $ | — | | | — | | | $ | 39 | | |
November 1 - 30, 2024 | | — | | | — | | | — | | | 39 | | |
December 1 - 31, 2024 | | — | | | — | | | — | | | 39 | | |
Total | | — | | | $ | — | | | — | | | | |
(1)On February 7, 2023, our Board of Directors approved an on market share buyback of up to $100 million of ordinary shares and/or CDIs during the following twelve months. On February 6, 2024, our Board of Directors extended the approval for the remaining $39 million of ordinary shares and/or CDIs of the $100 million buyback for an additional twelve months. The timing, volume, and nature of share repurchases may be amended, suspended, or discontinued at any time.
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
During the three months ended December 31, 2024, no director or Section 16 officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
Item 6. Exhibits
The documents in the accompanying Exhibits Index are filed, furnished, or incorporated by reference as part of this Quarterly Report on Form 10-Q, and such Exhibits Index is incorporated herein by reference.
| | | | | | | | | | | | | | | |
Exhibit | | Description | | |
2 | .1 | | | | |
10 | .1 | | | | |
22 | | | | | |
31 | .1 | | | | |
31 | .2 | | | | |
32 | | | | | |
101 | .INS | | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document. | | |
101 | .SCH | | Inline XBRL Taxonomy Extension Schema Document. | | |
101 | .CAL | | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | | |
101 | .DEF | | Inline XBRL Taxonomy Extension Definition Linkbase Document. | | |
101 | .LAB | | Inline XBRL Taxonomy Extension Label Linkbase Document. | | |
101 | .PRE | | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | | |
104 | | | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | | |
* This exhibit is a management contract or compensatory plan or arrangement.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. | | | | | | | | | | | |
| | | AMCOR PLC |
| | | |
| | | |
Date | February 5, 2025 | By | /s/ Michael Casamento |
| | | Michael Casamento, Executive Vice President and Chief Financial Officer (Principal Financial Officer) |
| | | |
Date | February 5, 2025 | By | /s/ Julie Sorrells |
| | | Julie Sorrells, Vice President and Corporate Controller (Principal Accounting Officer) |